<SEC-DOCUMENT>0001558370-20-006724.txt : 20200515
<SEC-HEADER>0001558370-20-006724.hdr.sgml : 20200515
<ACCEPTANCE-DATETIME>20200515160444
ACCESSION NUMBER:		0001558370-20-006724
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20200515
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200515
DATE AS OF CHANGE:		20200515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Editas Medicine, Inc.
		CENTRAL INDEX KEY:			0001650664
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				464097528
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37687
		FILM NUMBER:		20884960

	BUSINESS ADDRESS:	
		STREET 1:		11 HURLEY ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		617-401-9000

	MAIL ADDRESS:	
		STREET 1:		11 HURLEY ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>edit-20200515x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.7401.38943 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 5/15/2020 8:04:21 PM -->
      <!-- iXBRL Library version: 1.0.7401.38955 -->
      <!-- iXBRL Service Job ID: 060ff61e-b681-4355-85e5-ebfa498e5a6f -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:edit="http://www.editasmedicine.com/20200515" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:EntityCentralIndexKey" id="Tc_PGcDyYl0XUm5vAszdqxcKg_2_1">0001650664</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:AmendmentFlag" id="Tc_HX22MgMDIUKd1UQfguPrTg_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="edit-20200515.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-15</xbrli:startDate><xbrli:endDate>2020-05-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:15.52pt;"><a id="_6bb3e728_7f0a_469a_8fbb_840da447ef8c"></a><p style="font-family:'Times New Roman';font-size:12pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">WASHINGTON, D.C. 20549</b></p><div style="font-family:'Times New Roman';font-size:13.5pt;margin-bottom:6pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:38.36%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman';font-size:18pt;font-weight:bold;text-align:center;margin:0pt 0pt 3pt 0pt;">FORM&#160;<ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:DocumentType" id="Narr_tOuBe7Po_UulwbtvYd364g">8-K</ix:nonNumeric></p><div style="font-family:'Times New Roman';font-size:13.5pt;margin-bottom:9pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:38.36%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">CURRENT REPORT<br />Pursuant to Section&#160;13 or 15(d)<br />of The Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="font-size:10pt;white-space:pre-wrap;">Date of Report (Date of earliest event reported):  </span><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_ftI-YgUDFU2eO5XdhOl90g"><span style="font-size:10pt;">May 15, 2020</span></ix:nonNumeric></p><div style="font-family:'Times New Roman';font-size:13.5pt;margin-bottom:6pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:38.36%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman';font-size:18pt;font-weight:bold;text-align:center;margin:0pt 0pt 3pt 0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:EntityRegistrantName" id="Narr_oYoUNf4No0a-WZa2MlvYhQ">Editas Medicine, Inc.</ix:nonNumeric></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">(Exact Name of Registrant as Specified in its Charter)</p><div style="font-family:'Times New Roman';font-size:13.5pt;margin-bottom:6pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:38.36%;border:none;margin:0 auto;"><a id="_3adfa712_def6_4d30_8ee6_bcc325048289"></a><a id="Tc__B_MHccpLUiOmeZ7YBew0Q_2_0"></a><a id="Tc_BON6HRm1y06L8dCB9z4aog_2_2"></a><a id="Tc_pZf0BWlF8kKunBZAN7QoOw_2_4"></a></div></div><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_X5uualFnzEKOCVjNzU8NqA_1_0"><b style="font-size:10pt;font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:EntityFileNumber" id="Tc_yssiStBleESOJH1ItaC1nQ_1_2"><b style="font-size:10pt;font-weight:bold;">001-37687</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:EntityTaxIdentificationNumber" id="Tc_id_D5l0qUU6aaSoNbIn1Fw_1_4"><b style="font-size:10pt;font-weight:bold;">46-4097528</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(State or Other Jurisdiction of Incorporation)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(Commission File Number)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(IRS Employer Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_96b041bf_580e_4f57_a6fd_8289c17b8595"></a><a id="Tc_S5JB8Bx1ZkybRVusT8FFSQ_1_0"></a><a id="Tc__FbHMXDC9k--PhnOoNXokQ_2_0"></a><a id="Tc_zn7dcx7veUKtkS0GyIVHAA_2_2"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:EntityAddressAddressLine1" id="Narr_gu4RpHEKfE6SpCEFHqwvfA"><b style="font-size:10pt;font-weight:bold;">11 Hurley Street</b></ix:nonNumeric><b style="font-size:10pt;font-weight:bold;"><br /></b><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:EntityAddressCityOrTown" id="Narr_6S5fpzbNUkG5irx_burKfQ"><b style="font-size:10pt;font-weight:bold;">Cambridge</b></ix:nonNumeric><b style="font-size:10pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_-uj_M6YbUU6evy2CEjvtLg"><b style="font-size:10pt;font-weight:bold;">Massachusetts</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:EntityAddressPostalZipCode" id="Tc_cPCTBxrnGkaEa2ktB6k8ZA_1_2"><b style="font-size:10pt;font-weight:bold;">02141</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(Address of Principal Executive Offices)</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="font-size:10pt;">Registrant&#8217;s telephone number, including area code:&#160;</span><b style="font-size:10pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:CityAreaCode" id="Narr_0wnWwttC8UujftRwrkLPAQ"><b style="font-size:10pt;font-weight:bold;">617</b></ix:nonNumeric><b style="font-size:10pt;font-weight:bold;">)&#160;</b><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:LocalPhoneNumber" id="Narr__mN_qAvY2ESZ1CC95dUDnw"><b style="font-size:10pt;font-weight:bold;">401-9000</b></ix:nonNumeric></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(Former Name or Former Address, if Changed Since Last Report)</p><div style="font-family:'Times New Roman';font-size:13.5pt;margin-bottom:6pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:38.36%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction&#160;A.2. below):</p><a id="_e66d1806_114f_4f24_b753_e9c0be25034d"></a><a id="Tc_CAHflZbIfU2yYvoZRpeFXg_2_1"></a><a id="Tc_TQMRf6VbxUC6glFYJn7vVg_4_1"></a><a id="Tc_3iQ5-nf4bUeo52FAtjyucg_6_1"></a><a id="Tc__w9BbPF-6UuE0_eMU64y-g_8_1"></a><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Tc_aWuDZkUNDkyYwCEexiQ8Xg_2_0"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17&#160;CFR&#160;230.425)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Tc_Ik-QeWLybEKKwJwqGO4ERA_4_0"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17&#160;CFR&#160;240.14a-12)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Tc_bKU1q5KtDE-G_MQbtzWmVQ_6_0"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17&#160;CFR&#160;240.14d-2(b))</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Tc_5PKFB8PcsU2pzAqpk06jmg_8_0"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</p></td></tr></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 6pt 0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><a id="_dcb8c928_e46c_434f_a26a_0d9cf6b41806"></a><a id="Tc_V_ylUWRXEkyQ_d3Piq2Hag_1_0"></a><a id="Tc_biJibd3FFEGIdn-X1vKMTg_1_1"></a><a id="Tc_8-ElDzyFrUODYxlhhXx30w_1_2"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td></tr><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading Symbol(s)</b></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of each exchange on which registered</b></p></td></tr><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:Security12bTitle" id="Tc_S0jQ6-83P0WJmCpKvECv9A_2_0"><span style="font-size:8pt;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" name="dei:TradingSymbol" id="Tc_q_3HHMfKW0ibolWfh_K7qQ_2_1"><span style="font-size:8pt;">EDIT</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_yvfb8Cmgm02dPMt_xT_QIw_2_2"><span style="font-size:8pt;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 6pt 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-<span style="white-space:pre-wrap;">2 of this chapter).    </span></p><p style="font-family:'Times New Roman';font-size:12pt;text-indent:36pt;margin:6pt 0pt 6pt 0pt;"><span style="font-size:10pt;">Emerging growth company&#160;</span><ix:nonNumeric contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_iwvi-4VRGkyGYZ-MWa07gg"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman';font-size:10pt;margin:6pt 0pt 6pt 0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span>&#160;</p><p style="font-family:'Times New Roman';font-size:3pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:3pt;margin:0pt;">&#160;</p><p style="display:none;font-size:12pt;line-height:0pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_38fec2ac_ecf0_4ca2_876d_e68f20111f99"></a></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_Hlk535744647"></a><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item&#160;</b><b style="font-weight:bold;">1.01.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b style="font-weight:bold;">Entry into a Material Definitive Agreement.</b></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On May 15, 2020, Editas Medicine, Inc. (the &quot;Company&quot;) entered into a Common Stock Sales Agreement (the &quot;Sales Agreement&quot;) with Cowen and Company, LLC, as agent (&quot;Cowen&quot;), pursuant to which the Company may issue and sell shares of its common stock, $0.0001 par value per share, having an aggregate offering price of up to $150,000,000 (the &quot;Shares&quot;), from time to time through Cowen (the &quot;Offering&quot;). Also, on May 15, 2020, the Company is filing a prospectus supplement with the Securities and Exchange Commission in connection with the Offering (the &quot;Prospectus Supplement&quot;) under its existing automatic shelf registration statement, which became effective on March 12, 2018 (File No. 333-223596), and the base prospectus contained therein.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Upon delivery of a placement notice, and subject to the terms and conditions of the Sales Agreement, Cowen may sell the Shares by methods deemed to be an &quot;at the market offering&quot; as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended. The Company may sell the Shares in amounts and at times to be determined by the Company from time to time subject to the terms and conditions of the Sales Agreement, but it has no obligation to sell any of the Shares in the Offering.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company or Cowen may suspend or terminate the Offering upon notice to the other party and subject to other conditions. Cowen will act as sales agent on a commercially reasonable efforts basis consistent with its normal trading and sales practices and applicable state and federal law, rules and regulations and the rules of The Nasdaq Global Select Market.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has agreed to pay Cowen commissions for its services in acting as agent in the sale of the Shares in the amount of up to 3.0% of gross proceeds from the sale of the Shares pursuant to the Sales Agreement. The Company has also agreed to provide Cowen with customary indemnification and contribution rights.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A copy of the Sales Agreement is attached as Exhibit 1.1 hereto and is incorporated herein by reference. The foregoing description of the material terms of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to such exhibit.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Company, has issued a legal opinion relating to the Shares. A copy of such legal opinion, including the consent included therein, is attached as Exhibit 5.1 hereto.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Shares are registered pursuant to an effective shelf Registration Statement on Form S-3 (File No. 333-223596) and the base prospectus contained therein, and offerings for the Shares will be made only by means of the Prospectus Supplement. This Current Report on Form 8-K shall not constitute an offer to sell or solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of such state or jurisdiction.</p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item&#160;9.01.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b style="font-weight:bold;">Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:19.45pt;margin:0pt 0pt 12pt 0pt;">(d)&#160;Exhibits</p><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:6.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:91.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:6.77%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Exhibit<br />No.</b></p></td><td style="vertical-align:bottom;width:2.08%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:91.14%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:top;width:6.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">1.1</p></td><td style="vertical-align:bottom;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:91.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><a href="edit-20200515xex1d1.htm"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Common Stock Sales Agreement, dated as of May 15, 2020, by and between the Company and Cowen</span></a> </p></td></tr><tr><td style="vertical-align:bottom;width:6.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">5.1</p></td><td style="vertical-align:bottom;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:91.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="edit-20200515xex5d1.htm"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Opinion of Wilmer Cutler Pickering Hale and Dorr LLP</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:6.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">23.1</p></td><td style="vertical-align:bottom;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:91.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="edit-20200515xex5d1.htm"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Consent of Wilmer Cutler Pickering Hale and Dorr LLP (included in Exhibit 5.1)</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:6.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:91.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</p></td></tr></table><p style="background-color:#ffffff;font-family:'Times New Roman';font-size:12pt;margin:14pt 0pt 0pt 0pt;"><span style="font-size:1pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:14pt 0pt 12pt 0pt;"><span style="font-size:13.5pt;visibility:hidden;">&#8203;</span></p><a id="_8f9f64c6_d44b_4448_bd59_c00f07621b52"></a></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:76.47%;border:0;margin:30pt 11.76% 30pt 11.76%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">SIGNATURES</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:47.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">EDITAS MEDICINE, INC.</p></td></tr><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:47.98%;margin:0pt;padding:0pt;"></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Date:</p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">May 15, 2020</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:43.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">/s/ Michelle Robertson</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:43.99%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Michelle Robertson <br />Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>edit-20200515xex1d1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<!--HTML document created with Toppan Merrill Bridge  9.6.0.116-->
<!--Created on: 5/15/2020 2:04:16 PM-->
<html>
	<head>
		<title>
			edit_Ex1_1
		</title>
	</head>
	<body><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p style="margin:0pt;text-align:right;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;">Exhibit 1.1</font>
		</p>
		<p style="margin:0pt;text-align:center;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;">Editas Medicine, Inc.</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;">$150,000,000</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">COMMON STOCK</font>
		</p>
		<p style="margin:0pt;text-align:center;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">SALES AGREEMENT</font>
		</p>
		<p style="margin:0pt 0pt 5pt;text-align:right;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">May </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">15</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, 2020</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Cowen and Company, LLC</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">599 Lexington Avenue</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">New York, NY 10022</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Ladies and Gentlemen:</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Editas Medicine, Inc., a Delaware corporation (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Company</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;), confirms its agreement (this &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;) with Cowen and Company, LLC (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Cowen</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;), as follows:</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">1.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Issuance and Sale of Shares</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the conditions set forth herein and any Terms Agreement (defined below), it may issue and sell to or through Cowen, acting as agent and/or principal, shares (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Shares</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) of the Company&#x2019;s common stock, par value $0.0001 per share (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Common Stock</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), having an aggregate offering price of up to $</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">150,000,000</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section 1</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> on the number of shares of Common Stock issued and sold under this Agreement and any Terms Agreement shall be the sole responsibility of the Company, and Cowen shall have no obligation in connection with such compliance. The issuance and sale of Common Stock through Cowen will be effected pursuant to the Registration Statement (as defined below) filed by the Company with the Securities and Exchange Commission (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Commission</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement (as defined below) to issue the Common Stock.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">The Company has filed, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Securities Act</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;), with the Commission a registration statement on Form S-3 (File No. 333-223596), including a base prospectus (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Base Prospectus</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;), relating to certain securities, including the Common Stock, to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Exchange Act</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;). The Company has prepared a prospectus specifically relating to the Shares supplemental to the Base Prospectus (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Prospectus Supplement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;) and included as part of such registration statement. The Company has furnished to Cowen, for use by Cowen, copies of the Base Prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating to the Shares. Except where the context otherwise requires, such registration statement, as amended when it became effective, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B of the Securities Act, is herein called the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Registration Statement.</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D; The Base Prospectus,</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">including all documents incorporated therein by reference, included in the Registration Statement, as it may be supplemented by the Prospectus Supplement, in the form in which such Base Prospectus and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act, together with any &#x201C;issuer free writing prospectus,&#x201D; as defined in Rule 433 of the Securities Act (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Rule 433</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;), relating to the Shares that (i) is consented to by Cowen (including any free writing prospectus prepared by the Company solely for use in connection with the offering contemplated by a particular Terms Agreement), hereinafter referred to as a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Permitted Free Writing Prospectus</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">,&#x201D; (ii) is required to be filed with the Commission by the Company or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i), in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#x2019;s records pursuant to Rule 433(g), is herein called the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Prospectus</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">.&#x201D; Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms &#x201C;amend,&#x201D; &#x201C;amendment&#x201D; or &#x201C;supplement&#x201D; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission deemed to be incorporated by reference therein. For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include any copy filed with the Commission pursuant to the Electronic Data Gathering Analysis and Retrieval System or any successor thereto (collectively &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">EDGAR</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;).</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">2.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Agency and Principal Transactions.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Each time that the Company wishes to issue and sell the Shares hereunder through Cowen, acting as agent (each, an &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Agency Transaction</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), it will notify Cowen by email notice (or other method mutually agreed to in writing by the parties) (a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Placement Notice</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) containing the parameters in accordance with which it desires the Shares to be sold, which shall at a minimum include the number of Shares to be issued, the time period during which sales are requested to be made, any limitation on the number of Shares that may be sold in any one Trading Day (as defined in Section &#x200E;3) and any minimum price below which sales may not be made, a form of which containing such minimum sales parameters necessary is attached hereto as </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 1</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Placement Notice shall originate from any of the individuals from the Company set forth on </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 2</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from Cowen set forth on </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 2</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, as such </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 2</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> may be amended from time to time. The Placement Notice shall be effective upon receipt by Cowen unless and until (i) in accordance with the notice requirements set forth in Section &#x200E;4, Cowen declines to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Shares thereunder have been sold, (iii) in accordance with the notice requirements set forth in Section &#x200E;4, the Company suspends or terminates the Placement Notice for any reason in its sole discretion, (iv) the Company issues a subsequent Placement Notice with parameters superseding those on the earlier dated Placement Notice, or (v) this Agreement has been terminated under the provisions of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Section &#x200E;11</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The amount of any discount, commission or other compensation to be paid by the Company to Cowen in connection with the sale of the Shares shall be calculated in accordance with the terms set forth in </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 3</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. It is expressly acknowledged and agreed that neither the Company nor Cowen will have any obligation whatsoever with respect to an Agency Transaction or any Shares unless and until the Company delivers a Placement Notice to Cowen and Cowen does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">2</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">The Company may also offer to sell the Shares directly to Cowen, as principal, in which event such parties shall enter into a separate agreement (each, a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Terms Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) in substantially the form of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 2(b)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereto (with such changes thereto as may be agreed upon by the Company and Cowen), relating to such sale in accordance with Section 3(b) hereof (each such transaction being referred to as a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Principal Transaction</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">3.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Sale of Shares by Cowen.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Subject to the terms and conditions herein set forth, upon the Company&#x2019;s delivery of a Placement Notice with respect to an Agency Transaction, and unless the sale of the Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, Cowen, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of The Nasdaq Stock Market LLC (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Nasdaq</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) to sell such Shares up to the amount specified in such Placement Notice, and otherwise in accordance with the terms of such Placement Notice. Cowen will provide written confirmation to the Company (including by email correspondence to each of the individuals of the Company set forth on </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 2</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Shares hereunder setting forth the number of Shares sold on such day, the volume-weighted average price of the Shares sold, and the Net Proceeds (as defined below) payable to the Company. In the event the Company engages Cowen for a sale of Shares in an Agency Transaction that would constitute a &#x201C;block&#x201D; within the meaning of Rule 10b-18(a)(5) under the Exchange Act (a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Block Sale</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), the Company will provide Cowen, at Cowen&#x2019;s request and upon reasonable advance notice to the Company, on or prior to the Settlement Date, the opinions of counsel, accountant&#x2019;s letter and officers&#x2019; certificates set forth in </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Section 8</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereof, each dated the Settlement Date, and such other documents and information as Cowen shall reasonably request. Subject to the terms of a Placement Notice, Cowen may sell Shares by any method permitted by law deemed to be an &#x201C;at the market offering&#x201D; as defined in Rule 415 of the Securities Act. Notwithstanding the provisions of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section 6(kk)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, Cowen shall not purchase Shares with respect to an Agency Transaction for its own account as principal unless expressly authorized to do so by the Company in a Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance that Cowen will be successful in selling Shares in an Agency Transaction, and (ii) Cowen will incur no liability or obligation to the Company or any other person or entity if it does not sell Shares in an Agency Transaction for any reason other than a failure by Cowen to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Shares as required under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;3</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. For the purposes hereof, &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Trading Day</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D; means any day on which the Company&#x2019;s Common Stock is purchased and sold on the principal market on which the Common Stock is listed or quoted.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">(i) If the Company wishes to issue and sell the Shares to Cowen pursuant to this Agreement in a Principal Transaction, it will notify Cowen of the proposed terms of the Principal Transaction. If Cowen, acting as principal, wishes to accept such proposed terms (which it may decline to do for any reason in its sole discretion) or, following discussions with the Company, wishes to accept amended terms, the Company and Cowen shall enter into a Terms Agreement setting forth the terms of such Principal Transaction.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">(ii) The terms set forth in a Terms Agreement shall not be binding on the Company or Cowen unless and until the Company and Cowen have each executed and delivered such Terms Agreement</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">3</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">accepting all of the terms of such Terms Agreement. In the event of a conflict between the terms of this Agreement and the terms of a Terms Agreement, the terms of such Terms Agreement shall control.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">(iii) Each sale of the Shares to Cowen in a Principal Transaction shall be made in accordance with the terms of this Agreement and a Terms Agreement, which shall provide for the sale of such Shares to, and the purchase thereof by, Cowen. A Terms Agreement may also specify certain provisions relating to the reoffering of such Shares by Cowen. The commitment of Cowen to purchase the Shares pursuant to any Terms Agreement shall be deemed to have been made on the basis of the representations, warranties and agreements of the Company contained, and shall be subject to the terms and conditions set forth, in this Agreement and such Terms Agreement. Any such Terms Agreement shall specify the number of the Shares to be purchased by Cowen pursuant thereto, the price to be paid to the Company for such Shares, any provisions relating to rights of, and default by, Cowen in the reoffering of the Shares, and the time, date (each such time and date being referred to herein as a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Principal Settlement Date</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) and place of delivery of and payment for such Shares.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(c)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Notwithstanding any other provision of this Agreement, the Company shall not offer, sell or deliver, or request the offer or sale, of any Shares pursuant to this Agreement (whether in an Agency Transaction or a Principal Transaction) and, by notice to Cowen given by telephone (confirmed promptly by email), shall cancel any instructions for the offer or sale of any Shares, and Cowen shall not be obligated to offer or sell any Shares, (i) during any period in which the Company is, or could be deemed to be, in possession of material non-public information, or (ii) at any time from and including the date on which the Company shall issue a press release containing, or shall otherwise publicly announce, its earnings, revenues or other results of operations (an &#x201C;Earnings Announcement&#x201D;) through and including the time that the Company files a Quarterly Report on Form 10-Q or an Annual Report on Form 10-K that includes consolidated financial statements as of and for the same period or periods, as the case may be, covered by such Earnings Announcement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">4.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Suspension of Sales.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">The Company or Cowen may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 2</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to each of the individuals of the other party set forth on </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 2</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">), suspend any sale of Shares; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided, however</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, that such suspension shall not affect or impair either party&#x2019;s obligations with respect to any Shares sold hereunder prior to the receipt of such notice. Each of the parties agrees that no such notice under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;4</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> shall be effective against the other unless it is made to one of the individuals named on </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Schedule 2</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereto, as such schedule may be amended in writing from time to time.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">If either Cowen or the Company has reason to believe that the exemptive provisions set forth in Rule 101(c)(1) of Regulation M under the Exchange Act are not satisfied with respect to the Common Stock, it shall promptly notify the other party, and Cowen may, at its sole discretion, suspend sales of the Shares under this Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(c)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Notwithstanding any other provision of this Agreement, during any period in which the Registration Statement is no longer effective under the Securities Act, the Company shall promptly notify Cowen, the Company shall not request the sale of any Shares and Cowen shall not be obligated to sell or offer to sell any Shares.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">4</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">5.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Settlement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Settlement of Shares</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Unless otherwise specified in the applicable Placement Notice, settlement for sales of Shares in an Agency Transaction will occur on the second (2</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;font-size:6pt;top:-4.8pt;position:relative;line-height:100%">nd</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each, an &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Agency Settlement Date</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D; and the first such Agency Settlement Date, the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">First Delivery Date</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;; and any Agency Settlement Date and Principal Settlement Date shall be referred to as a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Settlement Date</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;). The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Shares sold in an Agency Transaction (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Net Proceeds</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) will be equal to the aggregate sales price received by Cowen at which such Shares were sold, after deduction for (i) Cowen&#x2019;s commission, discount or other compensation for such sales payable by the Company pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;2</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereof or pursuant to any applicable Terms Agreement, (ii) any other amounts due and payable by the Company to Cowen hereunder pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(h)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (Expenses) hereof, and (iii) any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales.&nbsp;&nbsp;The settlement for sales of Shares in a Principal Transaction will occur on such date against delivery of such proceeds to the Company as is specified in the applicable Terms Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Delivery of Shares</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Shares being sold by crediting Cowen&#x2019;s or its designee&#x2019;s account (provided Cowen shall have given the Company written notice of such designee at least one Trading Day prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradeable, transferable, registered shares in good deliverable form. On each Settlement Date, Cowen will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date. The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver duly authorized Shares on a Settlement Date through no fault of Cowen, the Company agrees that in addition to and in no way limiting the rights and obligations set forth in </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(a)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (Indemnification and Contribution&#x2014; Company Indemnification) hereto, it will (i) hold Cowen harmless against any loss, claim, damage, or reasonable and documented expense (including reasonable and documented legal fees and expenses), as incurred, arising out of or in connection with such default by the Company and (ii) pay to Cowen (without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such default.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">6.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Representations and Warranties of the Company</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Except as disclosed in the Registration Statement or the Prospectus, the Company represents and warrants to, and agrees with, Cowen that, unless such representation, warranty or agreement specifies a different time, as of the date of this Agreement and as of each Applicable Time (as defined in </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;20(a))</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, unless otherwise provided:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Compliance with Registration Requirements</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">The Company meets the requirements for use of Form S-3 under the Securities Act and is, and has been at all times relevant with respect to the registration of the offer and sale of the Shares, a &#x201C;well-known seasoned issuer&#x201D; as defined in Rule 405 under the Securities Act. The Registration Statement became effective upon filing with the Commission. The Company has complied to the Commission&#x2019;s satisfaction with all requests of the Commission for additional or supplemental information relevant with respect to the registration of the offer and sale of the Shares. No stop order suspending the effectiveness of the Registration Statement is in effect, and no proceedings for such purpose are pending before or, to the knowledge of the Company, threatened by the Commission. The sale of the Shares hereunder meets the requirements of General Instruction I.B.1 of Form S-3.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">5</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">No Misstatement or Omission</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">(i) Each document, if any, filed or to be filed pursuant to the Exchange Act and incorporated by reference in the Registration Statement or the Prospectus complied or will comply when so filed in all material respects with the Exchange Act and the applicable rules and regulations of the Commission thereunder, (ii) each part of the Registration Statement, when such part became effective, did not contain, and each such part, as amended or supplemented, if applicable, will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (iii) the Registration Statement does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (iv) the Registration Statement and the Prospectus comply and, as amended or supplemented, if applicable, will comply in all material respects with the Securities Act and the applicable rules and regulations of the Commission thereunder, (v) each broadly available road show, if any, when considered together with the Prospectus, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading and (vi) as of its date and each Applicable Time, the Prospectus does not contain and, as amended or supplemented, if applicable, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the representations and warranties set forth in this paragraph do not apply to statements or omissions in the Registration Statement or the Prospectus based upon any Agent Information. As used herein, &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Time of Sale</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D; means (i) with respect to each offering of Shares in an Agency Transaction pursuant to this Agreement, the time of Cowen&#x2019;s initial entry into contracts with purchasers for the sale of such Shares and (ii) with respect to each offering of Shares pursuant to any relevant Terms Agreement, the time of sale of such Shares to Cowen.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(c)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Ineligible Issuer Status</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">The Company is not an &#x201C;ineligible issuer&#x201D; in connection with the offering pursuant to Rules 164, 405 and 433 under the Securities Act.&nbsp;&nbsp;Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder.&nbsp;&nbsp;Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or on behalf of or used or referred to by the Company complies or will comply in all material respects with the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(d)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Exchange Act Compliance</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. The documents incorporated or deemed to be incorporated by reference in the Prospectus, at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with the requirements of the Exchange Act, and, when read together with the other information in the Prospectus, at the Settlement Dates, will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(e)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Good Standing of the Company.</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> The Company has been duly incorporated, is validly existing as a corporation in good standing under the laws of the State of Delaware, has the corporate power and authority to own its property and to conduct its business as described in the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not have a material adverse effect on the Company and its subsidiaries, taken as a whole.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">6</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(f)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:TimesNewRoman;font-size:12pt;text-decoration:underline;">Good Standing of Subsidiaries</font><font style="display:inline;font-family:TimesNewRoman;font-size:12pt;">. Each </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">subsidiary</font><font style="display:inline;font-family:TimesNewRoman;font-size:12pt;"> of the Company has been duly incorporated, is validly existing as a corporation in good standing under the laws of the jurisdiction of its incorporation, has the corporate power and authority to own its property and to conduct its business as described in the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not have a material adverse effect on the Company and its subsidiaries, taken as a whole; all of the issued shares of capital stock of each subsidiary of the Company have been duly and validly authorized and issued, are fully paid and non-assessable and are owned directly by the Company, free and clear of all liens, encumbrances, equities or claims.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(g)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">The Sales Agreement; Terms Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. This Agreement has been duly authorized, executed and delivered by the Company. Any Terms Agreement will have been duly authorized, executed and delivered by the Company.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(h)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Finder&#x2019;s Fee</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Except as disclosed in the Prospectus and</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> except as may otherwise exist with respect to Cowen pursuant to this Agreement and any Terms Agreement and any other agreement entered into between the Company and Cowen in connection with the offer and sale of Shares pursuant to this Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, there are no contracts, agreements or understandings between the Company and any person that would give rise to a valid claim against the Company or Cowen for a brokerage commission, finder&#x2019;s fee or other like payment in connection with any transactions contemplated by this Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(i)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Authorization of the Common Stock</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. (i) </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">The authorized capital stock of the Company conforms in all material respects as to legal matters to the description thereof contained in the Registration Statement and the Prospectus; (ii) the shares of Common Stock outstanding on the date of this Agreement </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">and any Terms Agreement </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">have been duly authorized and are validly issued, fully paid and non&#8209;assessable, and (iii) the Shares have been duly authorized and, when issued and delivered in accordance with the terms of this Agreement and any Terms Agreement, will be validly issued, fully paid and non&#8209;assessable, and the issuance of such Shares will not be subject to any preemptive or similar rights that have not been validly waived.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(j)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Ownership of Real Property; Title to Property</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. As of the date of this Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> and any Terms Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, the Company and its subsidiaries do not own any real property; except as disclosed in the Prospectus, the Company and its subsidiaries will have good and marketable title in fee simple to all real property acquired after the date hereof that is material to the business of the Company and its subsidiaries, taken as a whole. The Company and its subsidiaries have good and marketable title to all personal property owned by them which is material to the business of the Company and its subsidiaries, taken as a whole, in each case free and clear of all liens, encumbrances and defects except such as are described in the Prospectus or such as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not materially interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries, in each case except as described in the Prospectus.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(k)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Absence of Defaults and Conflicts Resulting from Transaction; Absence of Further Requirements</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> and any Terms Agreement </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">will not contravene any provision of the certificate of incorporation or by&#8209;laws of the Company or any agreement or other instrument binding</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">7</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">upon the Company or any of its subsidiaries that is material to the Company and its subsidiaries, taken as a whole, or any applicable law or statute or any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company or any subsidiary, and no consent, approval, authorization or order of, or qualification with, any governmental body or agency is required for the performance by the Company of its obligations under this Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> and any Terms Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, except such as have already been obtained or made or as may be required by the securities or Blue Sky laws of the various states in connection with the offer and sale of the Shares.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(l)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Absence of Existing Defaults and Conflicts</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Neither the Company nor any of its subsidiaries is (i) in violation of any provision of its own certificate of incorporation or by-laws, (ii) in default, and, to the knowledge of the Company, no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any agreement or other instrument binding upon the Company or any of its subsidiaries, in either case to the extent that such default has had or would reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole, or (iii) in violation of any applicable law or statute or any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company or any subsidiary.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(m)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Material Adverse Change</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. There has not occurred any material adverse change, or any development that would reasonably be expected to result in a material adverse change, in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Prospectus.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(n)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Legal or Governmental Proceedings</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. There are no legal or governmental proceedings pending or, to the knowledge of the Company, threatened to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject (i) other than proceedings accurately described in all material respects in the Prospectus and proceedings that would not have a material adverse effect on the Company and its subsidiaries, taken as a whole, or on the power or ability of the Company to perform its obligations under this Agreement or to consummate the transactions contemplated by the Prospectus or (ii) that are required to be described in the Registration Statement or the Prospectus and are not so described; and there are no statutes, regulations, contracts or other documents that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement that are not described or filed as required.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(o)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">424(b) Prospectuses</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Each preliminary prospectus relating to the offer and sale of the Shares filed as part of the Registration Statement as originally filed or as part of any amendment thereto, or filed pursuant to Rule&nbsp;424 under the Securities Act, complied when so filed in all material respects with the Securities Act and the applicable rules and regulations of the Commission thereunder.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(p)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Investment Company</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company is not, and after giving effect to the offering and sale of any of the Shares and the application of the proceeds thereof as described in the Prospectus will not be, required to register as an &#x201C;investment company&#x201D; as such term is defined in the Investment Company Act of 1940, as amended (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Investment Company Act</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(q)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Compliance with Environmental Laws</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company and its subsidiaries (i) are in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Environmental Laws</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">8</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">and (iii) are in compliance with all terms and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would not, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole. There are no costs or liabilities associated with Environmental Laws (including, without limitation, any capital or operating expenditures required for clean&#8209;up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties) which would, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(r)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Clinical Trials</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. (i) The feasibility, pre-clinical or clinical trials and other studies or tests (x) conducted by or on behalf of or sponsored by the Company or any of its subsidiaries, or (y) in which the Company or any of its subsidiaries has participated, that are described in the Prospectus, or the results of which are referred to in the Prospectus, as applicable, were, and if still pending, are being conducted in all material respects in accordance with standard medical and scientific research standards and procedures for products or product candidates comparable to those being developed by the Company or any of its subsidiaries and all applicable statutes and all applicable rules, regulations and guidance documents of the U.S. Food and Drug Administration (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">FDA</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) and comparable regulatory agencies outside of the United States to which they are subject, including the European Commission and the European Medicines Agency (collectively, the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Regulatory Authorities</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) and current Good Clinical Practices and Good Laboratory Practices; (ii) the descriptions in the Prospectus of the results of such trials, studies and tests are, in all material respects, accurate and complete descriptions and fairly present the material data derived therefrom; (iii) the Company has no knowledge of any other trials, studies or tests (x) conducted by or on behalf of or sponsored by the Company or any of its subsidiaries, or (y) in which the Company or any of its subsidiaries has participated, not described in the Prospectus, the results of which are materially inconsistent with or raise questions concerning the validity of the results described or referred to in the Prospectus; (iv) the Company and its subsidiaries have operated at all times and are currently in compliance in all material respects with all applicable statutes, rules, regulations, standards, guidelines and orders administered or issued by any Regulatory Authority; and (v) neither the Company nor any of its subsidiaries has received any written notices, correspondence or other communications from the Regulatory Authorities or any court or arbitrator or other governmental or regulatory body, agency or authority requiring or threatening the termination, modification or suspension of any feasibility, clinical or pre-clinical trials or other studies or tests that are described in the Prospectus or the results of which are referred to in the Prospectus, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials and tests, and there are no reasonable grounds for the same.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(s)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Compliance with Regulatory Requirements</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Neither the Company nor any of its subsidiaries has failed to file with the Regulatory Authorities any required filing, declaration, listing, registration, report or submission with respect to the Company&#x2019;s or any subsidiary&#x2019;s product candidates or feasibility, pre-clinical or clinical trials or other studies or tests that are described or referred to in the Prospectus; all such filings, declarations, listings, registrations, reports or submissions were in compliance in all material respects with applicable laws when filed; and no deficiencies regarding material compliance with applicable law have been asserted by any applicable Regulatory Authority with respect to any such filings, declarations, listings, registrations, reports or submissions.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(t)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Possession of Licenses and Permits</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company and its subsidiaries possess all licenses, certificates, permits and other authorizations issued by, and have made all declarations and filings with,</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">9</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Prospectus, and neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such license, certificate, permit or authorization or has any reason to believe that any such license, certificate, permit or authorization will not be renewed in the ordinary course. The Company and its subsidiaries (i) are, and at all times have been, in compliance in all material respects with all statutes, rules, regulations, standards, guidelines and orders administered or issued by any Regulatory Authority or applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, storage, import, export or disposal of any product manufactured or distributed by the Company or any of its subsidiaries (collectively, &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Applicable Laws</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), and (ii) have not received any FDA Form 483, written notice of adverse finding, warning letter, untitled letter or other correspondence or written notice from any court or arbitrator or governmental or regulatory body, agency or authority alleging or asserting non-compliance with (x) any Applicable Laws or (y) any licenses, exemptions, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws. Neither the </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Company nor any of its subsidiaries has received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental or regulatory body, agency or authority or third party alleging that any operation or activity is in material violation of any Applicable Laws, and, to the knowledge of the Company, no such notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action is threatened. Neither the Company nor any of its subsidiaries is a party to any corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory body, agency or authority. Additionally, to the Company&#x2019;s knowledge, none of the employees, officers or directors of the Company or any of its subsidiaries has been excluded, suspended or debarred from participation in any U.S. federal health care program, clinical or pre-clinical research or comparable foreign program or is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension, or exclusion.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(u)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Status of Material Contracts</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Neither the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew, any of the contracts or agreements referred to or described in the Prospectus or filed as an exhibit to the Registration Statement, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to the Company&#x2019;s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(v)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">No Applicable Registration or Other Similar Rights</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. There are no contracts, agreements or understandings between the Company and any person granting such person the right to require the Company to file a registration statement under the Securities Act with respect to any securities of the Company or to require the Company to include such securities with the Shares registered pursuant to the Registration Statement, other than any such rights that are described in the Prospectus and have been validly waived in connection with the filing of the Registration Statement and the sale of the Shares.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(w)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Statistical and Market-Related Data</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Any third-party statistical and market-related data included or incorporated by reference in the Registration Statement or Prospectus are based on or derived from sources that the Company believes to be reliable and accurate.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(x)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Anti-Corruption</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. (i) Neither the Company nor any of its subsidiaries, nor any director or officer thereof, nor, to the Company&#x2019;s knowledge, any employee or affiliate of the Company or any of</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">10</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">its subsidiaries or any agent or representative of the Company or of any of its subsidiaries or affiliates, has taken or will take any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment, giving or receipt of money, property, gifts or anything else of value, directly or indirectly, to any &#x201C;government official&#x201D; (including any officer or employee of a government or government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office) (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Government Official</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), or to any person in violation of any applicable anti-corruption laws; (ii) the Company and its subsidiaries and, to the Company&#x2019;s knowledge, their respective affiliates have conducted their businesses in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies and procedures reasonably designed to promote and achieve compliance with such laws and with the representations and warranties contained herein; and (iii) neither the Company nor any of its subsidiaries will use, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of any applicable anti-corruption laws.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(y)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Anti-Money Laundering</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The operations of the Company and its subsidiaries are and have been conducted at all times in material compliance with all applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company and its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Anti-Money Laundering Laws</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(z)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Economic Sanctions</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. (i) Neither the Company nor any of its subsidiaries, nor any director or officer thereof, nor, to the Company&#x2019;s knowledge, any employee or affiliate of the Company or any of its subsidiaries or any agent or representative of the Company or of any of its subsidiaries or affiliates is an individual or entity (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Person</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) that is, or is owned or controlled by one or more Persons that are:</font>
		</p>
		<p style="margin:0pt 0pt 12pt 72pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:21pt;"><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(A)</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">the subject of any sanctions administered or enforced by the U.S. Department of Treasury&#x2019;s Office of Foreign Assets Control (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">OFAC</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) , the United Nations Security Council (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">UNSC</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), the European Union (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">EU</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), Her Majesty&#x2019;s Treasury (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">HMT</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), or other relevant sanctions authority (collectively, &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Sanctions</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), or</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt 72pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:21pt;"><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(B)</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, the Crimea region, Cuba, Iran, North Korea and Syria).</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent:49.5pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(ii)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 35.1pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">The Company will not, directly or indirectly, use the Net Proceeds of the sale of the Shares, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person:</font>
		</p>
		<p style="margin:0pt 0pt 12pt 72pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:21pt;"><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(A)</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or</font></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">11</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt 72pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:21pt;"><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(B)</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise).</font></font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent:49.5pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(iii)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 31.5pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Since the Company&#x2019;s inception, the Company (including its predecessors) and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions, except as otherwise authorized by law.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(aa)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">No Liabilities, Repurchases or Material Changes</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Subsequent to the date as of which information is given in the Prospectus, (i) the Company and its subsidiaries have not incurred any material liability or obligation, direct or contingent, nor entered into any material transaction; (ii) the Company has not purchased any of its outstanding capital stock other than purchases of restricted common stock of the Company, which are individually and in the aggregate immaterial to the Company, pursuant to contractual rights of the Company in connection with the termination of the employment with the Company of the holders thereof, nor declared, paid or otherwise made any dividend or distribution of any kind on its capital stock other than ordinary and customary dividends; and (iii) there has not been any material change in the capital stock, short&#8209;term debt or long&#8209;term debt of the Company and its subsidiaries, except in each case as described in the Prospectus.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(bb)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Intellectual Property</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Except as described in the Prospectus, the Company and its subsidiaries own or possess, or believe they can acquire on commercially reasonable terms, adequate rights to use all patents, patent rights, licenses, copyrights, know&#8209;how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, trade names, domain names and other similar intellectual property or proprietary rights (including all registrations and applications for registration of, and all goodwill associated with, the foregoing) (collectively, &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Intellectual Property</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), in each case necessary for the conduct of the business of the Company and its subsidiaries in all material respects as currently conducted and as proposed to be conducted as described in the Prospectus. Except as described in the Prospectus and to the knowledge of the Company, neither the Company nor any of its subsidiaries has infringed, misappropriated or otherwise violated any Intellectual Property of any third party in any material respect.&nbsp;&nbsp;Except as described in the Prospectus, neither the Company nor any of its subsidiaries has received any written notice of infringement, misappropriation or other violation of, or conflict with, any Intellectual Property of any third party, or any written notice challenging the validity, enforceability or scope of any Intellectual Property owned by, or exclusively licensed to, the Company or any of its subsidiaries, in each case, which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a material adverse effect on the Company and its subsidiaries, taken as a whole.&nbsp;&nbsp;To the knowledge of the Company, all material Intellectual Property owned by, or exclusively licensed to, the Company and its subsidiaries is valid and enforceable.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(cc)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Cybersecurity and Data Privacy</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. (i)(x) To the knowledge of the Company, there has been no (A) security breach, (B) unauthorized destruction, loss, distribution, use, access, disablement or modification, or (C) misappropriation or other compromise or misuse (each of the foregoing subsections (A)-(C), a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Breach</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) of or relating to any of the Company&#x2019;s or its subsidiaries&#x2019; respective information technology or computer systems, networks, hardware, software, data (including Personal Data (as defined below) and the data of its customers, employees, suppliers, vendors and any third party data maintained by or on behalf of the Company or any of its subsidiaries), equipment or technology (collectively, the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">IT Systems and Data</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) and (y) neither the Company nor any of its subsidiaries has</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">12</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">been notified of, or has any knowledge of, any event or condition that would reasonably be expected to result in, any Breach of the IT Systems and Data, except as would not, in the case of this clause (i), individually or in the aggregate, have a material adverse effect; (ii) the Company and each of its subsidiaries has complied, and is presently in compliance, with all (A) applicable laws and statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority and (B)&nbsp;internal and external-facing policies and (C) contractual obligations, in each case relating to (x) the collection, use, transfer, import, export, storage, protection, disposal and/or disclosure of personally identifiable, household, confidential or regulated data or information (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Data Security Obligations</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;, and such data and information, &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Personal Data</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), (y) the privacy and security of the IT Systems and Data or (z) the protection of the IT Systems and Data from any Breach, except as would not, in the case of this clause (ii), individually or in the aggregate, have a material adverse effect;&nbsp;&nbsp;(iii) the Company and each of its subsidiaries has taken commercially reasonable steps to protect the IT Systems and Data, including by establishing, maintaining, implementing and complying with reasonable information technology, information security, cyber security and data protection controls, policies and procedures and technology, including oversight, access controls, encryption, technological and physical safeguards and business continuity/disaster recovery and security plans, that the Company reasonably believes are consistent with industry standards and practices and are designed to protect against and prevent any Breach of the IT Systems and Data; (iv)&nbsp;neither the Company nor any of its subsidiaries has received any complaint regarding any non-compliance with any Data Security Obligation by the Company or any of its subsidiaries; and (v) there is no action, suit or proceeding by or before any court or governmental agency, authority or body pending or, to the knowledge of the Company, threatened alleging non-compliance with any Data Security Obligation by the Company or any of its subsidiaries.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(dd)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Absence of Labor Dispute.</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> No material labor dispute with the employees of the Company or any of its subsidiaries exists, except as described in the Prospectus, or, to the knowledge of the Company, is imminent; and the Company is not aware of any existing, threatened or imminent labor disturbance by the employees of any of its principal suppliers, manufacturers or contractors that would reasonably be likely to have a material adverse effect on the Company and its subsidiaries, taken as a whole.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(ee)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Insurance</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company and each of its subsidiaries is insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are, in the reasonable judgment of the Company, prudent and customary in the business in which it is engaged; neither the Company nor any of its subsidiaries has been refused any insurance coverage sought or applied for; and neither the Company nor any of its subsidiaries has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a material adverse effect on the Company and its subsidiaries, taken as a whole, except as described in the Prospectus.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(ff)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Accounting Controls and Procedures</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company and each of its subsidiaries maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&#x2019;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with United States generally accepted accounting principles (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">U.S. GAAP</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;) and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&#x2019;s general or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v) the interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement is</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">13</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">accurate. Except as described in the Prospectus, since the end of the Company&#x2019;s most recent audited fiscal year, there has been (i) no material weakness in the Company&#x2019;s internal control over financial reporting (whether or not remediated) and (ii) no change in the Company&#x2019;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#x2019;s internal control over financial reporting.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(gg)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">eXtensible Business Reporting Language</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#x2019;s rules and guidelines applicable thereto.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(hh)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Taxes</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company and each of its subsidiaries has filed all federal, state, local and foreign tax returns required to be filed through the date of this Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> and any Terms Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> or has requested extensions thereof (except where the failure to file would not, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole) and has paid all taxes required to be paid thereon (except for cases in which the failure to file or pay would not, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole, or, except as currently being contested in good faith and for which reserves required by U.S. GAAP have been created in the financial statements of the Company), and no tax deficiency has been determined adversely to the Company or any of its subsidiaries which has had (nor does the Company or any of its subsidiaries have any notice or knowledge of any tax deficiency which could reasonably be expected to be determined adversely to the Company or its subsidiaries and which would reasonably be expected to have), individually or in the aggregate, a material adverse effect on the Company and its subsidiaries, taken as a whole.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(ii)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Independent Accountants</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Ernst &amp; Young LLP, who have certified certain financial statements of the Company, is an independent registered public accounting firm with respect to the Company within the meaning of the Securities Act and the applicable rules and regulations thereunder adopted by the Commission and the Public Company Accounting Oversight Board (United States).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(jj)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">No Reliance</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. The Company has not relied upon Cowen or legal counsel for Cowen for any legal, tax or accounting advice in connection with the offering and sale of the Shares.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(kk)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 21.6pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Cowen Purchases</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company acknowledges and agrees that Cowen has informed the Company that Cowen may, to the extent permitted under the Securities Act and the Exchange Act, purchase and sell shares of Common Stock for its own account while this Agreement is in effect, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided, that </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(i) no such purchase or sale shall take place while a Placement Notice is in effect (except to the extent Cowen may engage in sales of Shares purchased or deemed purchased from the Company as a &#x201C;riskless principal&#x201D; or in a similar capacity) and (ii) </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">the Company shall not be deemed to have authorized or consented to any such purchases or sales by Cowen.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Any certificate signed by an officer of the Company and delivered to Cowen or to counsel for Cowen pursuant to or in connection with this Agreement or any Terms Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to Cowen as to the matters set forth therein.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">The Company acknowledges that Cowen and, for purposes of the opinions to be delivered pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Section &#x200E;7</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> hereof, counsel to the Company and counsel to Cowen, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">14</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">7.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Covenants of the Company</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company covenants and agrees with Cowen that:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Registration Statement Amendments</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. After the date of this Agreement and during any period in which a Prospectus relating to any Shares is required to be delivered by Cowen under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or similar rule), (i) the Company will notify Cowen promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference, has been filed with the Commission and/or has become effective or any subsequent supplement to the Prospectus, other than documents incorporated by reference, has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus or for additional information, (ii) the Company will prepare and file with the Commission, promptly upon Cowen&#x2019;s reasonable request, any amendments or supplements to the Registration Statement or Prospectus that, in Cowen&#x2019;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Shares by Cowen (</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">provided, however</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, that the failure of Cowen to make such request shall not relieve the Company of any obligation or liability hereunder, or affect Cowen&#x2019;s right to rely on the representations and warranties made by the Company in this Agreement or any Terms Agreement) and </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">provided</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">further</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, that the only remedy Cowen shall have with respect to the failure by the Company to make such filing (other than Cowen&#x2019;s rights under </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> hereof) will be to cease making sales under this Agreement until such amendment or supplement is filed); (iii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus, other than documents incorporated by reference, relating to the Shares or a security convertible into the Shares unless a copy thereof has been submitted to Cowen within a reasonable period of time before the filing and Cowen has not reasonably objected thereto (</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">provided, however</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, that the failure of Cowen to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect Cowen&#x2019;s right to rely on the representations and warranties made by the Company in this Agreement and </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">provided, further, </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">that the only remedy Cowen shall have with respect to the failure to make such filing (other than Cowen&#x2019;s rights under Section 9 hereof) will be to cease making sales under this Agreement) and the Company will furnish to Cowen at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via EDGAR; (iv) the Company will cause each amendment or supplement to the Prospectus, other than documents incorporated by reference, to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act; and (v) prior to the termination of this Agreement, the Company will notify Cowen if at any time the Registration Statement shall no longer be effective as a result of the passage of time pursuant to Rule 415 under the Securities Act, due to the Company no longer qualifying as a &#x201C;well-known seasoned issuer&#x201D; pursuant to Rule 405 and Form S-3 or otherwise.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font>&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Notice of Commission Stop Orders</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. The Company will advise Cowen, promptly after it receives notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(c)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Delivery of Prospectus; Subsequent Changes</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. During any period in which a Prospectus relating to the Shares is required to be delivered by Cowen under the Securities Act with respect to a pending sale of the Shares, (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or similar rule), the Company will use its commercially reasonable efforts to comply with all requirements imposed upon it by the Securities Act, as from time</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">15</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">to time in force, and to file on or before their respective due dates (taking into account any extensions available under the Exchange Act) all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If during such period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify Cowen to suspend the offering of Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">; &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">provided</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">however</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, that the Company may delay the filing of any amendment or supplement, if in the judgment of the Company, it is in the best interest of the Company to do so</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(d)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Listing of Shares</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. During any period in which the Prospectus relating to the Shares is required to be delivered by Cowen under the Securities Act with respect to a pending sale of the Shares (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or similar rule), the Company will use its commercially reasonable efforts to cause the Shares to be listed on Nasdaq.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(e)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Delivery of Registration Statement and Prospectus</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company will furnish to Cowen and its counsel (at the expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during any period in which a Prospectus relating to the Shares is required to be delivered under the Securities Act (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as Cowen may from time to time reasonably request and, at Cowen&#x2019;s request, will also furnish copies of the Prospectus to each exchange or market on which sales of the Shares may be made; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided, however,</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> that the Company shall not be required to furnish any document (other than the Prospectus) to Cowen to the extent such document is available on EDGAR.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(f)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Blue Sky Laws</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.&nbsp;&nbsp;The Company shall endeavor to qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions in the United States as Cowen shall reasonably request and to continue such qualifications as in effect so long as required for the distribution of the Shares; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> that in connection therewith the Company shall not be required to qualify as a foreign corporation or dealer in securities or to file a general consent to service of process in any jurisdiction.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(g)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Earnings Statement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">. &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">The Company will make generally available to the Company&#x2019;s security holders and to Cowen, via a filing on EDGAR, as soon as practicable an earnings statement covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the date of this Agreement which shall satisfy the provisions of Section&nbsp;11(a) and Rule 158 of the Securities Act.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(h)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Expenses</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, in accordance with the provisions of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;11</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereunder, will pay all expenses incident to the performance of its obligations hereunder, including, but not limited to, expenses relating to (i) the preparation, printing and filing of the Registration Statement and each amendment and supplement thereto, of each Prospectus and Prospectus Supplement and of</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">16</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">each amendment and supplement thereto, (ii) the preparation, issuance and delivery of the Shares, (iii) the qualification of the Shares under securities laws in accordance with the provisions of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(f)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> of this Agreement, including filing fees (provided, however, that any fees or disbursements of counsel for Cowen in connection therewith shall be paid by Cowen except as set forth in (viii) below), (iv) the printing and delivery to Cowen of copies of the Prospectus and any amendments or supplements thereto, and of this Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> and any Terms Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, (v) the fees and expenses incurred in connection with the listing or qualification of the Shares for trading on Nasdaq, (vi) transfer taxes imposed on the issuance of Shares, (vii) </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">the costs and charges of any transfer agent, registrar or depositary</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, (viii) filing fees and expenses, if any, of the Commission and the FINRA Corporate Financing Department (including, with respect to any required review by FINRA, the reasonable fees and expenses of Cowen&#x2019;s counsel in an amount not to exceed $10,000), (ix) the fees and disbursements of Cowen&#x2019;s counsel in an amount not to exceed $50,000, and </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(x) all other costs and expenses incident to the performance of the obligations of the Company hereunder for which provision is not otherwise made in this Section.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(i)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Use of Proceeds</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company will use the Net Proceeds as described in the Prospectus in the section entitled &#x201C;Use of Proceeds.&#x201D;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(j)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Notice of Other Sales</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. During the pendency of any Placement Notice given hereunder, and for 5 trading days following the termination of any Placement Notice given hereunder, the Company shall provide Cowen notice as promptly as reasonably possible before it offers to sell, contracts to sell, sells, grants any option to sell or otherwise disposes of any shares of Common Stock (other than Shares offered pursuant to the provisions of this Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> or any Terms Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire Common Stock; provided, that such notice shall not be required in connection with the (i) issuance, grant or sale of Common Stock, options to purchase shares of Common Stock or Common Stock issuable upon the exercise of options or other equity awards pursuant to any stock option, stock bonus or other stock plan or arrangement described in the Prospectus, (ii) the issuance of securities in connection with an acquisition, merger or sale or purchase of assets; (iii) the issuance or sale of Common Stock pursuant to any dividend reinvestment plan that the Company may adopt from time to time provided the implementation of such is disclosed to Cowen in advance; (iv) the issuance of securities in satisfaction of contractual payment obligations described in the Prospectus, including the issuance of Common Stock in payment of indebtedness of the Company in accordance with the terms thereof; (v) the issuance of any shares of common stock issuable upon the exchange, conversion or redemption of securities or the exercise of warrants, options or other rights in effect or outstanding or described in the Prospectus; or (vi) the issuance of any shares of common stock, or securities convertible into or exercisable for common stock, offered and sold in a privately negotiated transaction to licensors, vendors, customers, investors, strategic partners or potential strategic partners and otherwise conducted in a manner so as not to be integrated with the offering of Shares contemplated hereby. Notwithstanding the foregoing provisions, nothing herein shall be construed to restrict the Company&#x2019;s ability to file, or require the Company to provide notice to Cowen of the filing of, a registration statement under the Securities Act.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(k)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Change of Circumstances</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company will, at any time during the pendency of a Placement Notice or sale of Shares hereunder or pursuant to a Terms Agreement, advise Cowen promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document provided to Cowen pursuant to this Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> or any Terms Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(l)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Due Diligence Cooperation</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company will cooperate with any reasonable due diligence review conducted by Cowen or its agents from time to time in connection with the transactions</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">17</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">contemplated hereby</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> or by any Terms Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, including, without limitation, providing information and making available documents and senior corporate officers, during regular business hours and at the Company&#x2019;s principal offices, as Cowen may reasonably request.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(m)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Required Filings Relating to Placement of Shares</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company agrees that on such dates as the Securities Act shall require, the Company will (i) file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act (each and every filing under Rule 424(b) relating to the Shares, a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Filing Date</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), which prospectus supplement will set forth, within the relevant period, the amount of Shares sold through Cowen, the Net Proceeds to the Company and the compensation payable by the Company to Cowen with respect to such Shares, and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(n)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Representation Dates; Certificate</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. On or prior to the First Delivery Date and each time thereafter during the term of this Agreement the Company (i) files the Prospectus relating to the Shares or amends or supplements the Registration Statement or the Prospectus relating to the Shares (other than a prospectus supplement filed in accordance with </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(m)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> of this Agreement) by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of document(s) by reference to the Registration Statement or the Prospectus relating to the Shares; (ii) files an annual report on Form 10-K under the Exchange Act; (iii) files a quarterly report on Form 10-Q under the Exchange Act; or (iv) files a report on Form 8-K containing amended financial information (other than an earnings release or other information &#x201C;furnished&#x201D;) under the Exchange Act (each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Representation Date</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">&#x201D;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">); the Company shall furnish Cowen (but in the case of clause (iv) above only if (1) a Placement Notice is pending, (2) Cowen reasonably determines that the information contained in such Form 8-K is material to a holder of Common Stock and (3) Cowen requests such certificate within three (3) days after the filing of such Form 8-K with the Commission) with a certificate, in the form attached hereto as </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Exhibit 7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> within three (3) Trading Days of any Representation Date if requested by Cowen. The requirement to provide a certificate under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> shall be automatically waived for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">however</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, that such waiver shall not apply for any Representation Date on which the Company files its annual report on Form 10-K. Notwithstanding the foregoing, if the Company subsequently decides to sell Shares in an Agency Transaction following a Representation Date when the Company relied on such waiver and did not provide Cowen with a certificate under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, then before the Company delivers the Placement Notice or Cowen sells any Shares pursuant to such Agency Transaction, the Company shall provide Cowen with a certificate, in the form attached hereto as </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Exhibit 7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, dated the date of the Placement Notice. With respect to any Principal Transaction pursuant to a Terms Agreement, the certificate in the form attached hereto as Exhibit 7(n) shall be delivered at the Principal Settlement Date.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(o)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Legal Opinions</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. On or prior to the First Delivery Date and within three (3) Trading Days of each Representation Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Exhibit 7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> for which no waiver is applicable, the Company shall cause to be furnished to Cowen:</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent:49.5pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(i)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 38.7pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">a written opinion or statement of Wilmer Cutler Pickering Hale and Dorr LLP (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Company Counsel</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), or other counsel reasonably satisfactory to Cowen, in form and</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">18</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">substance satisfactory to Cowen and its counsel, substantially similar to the form previously provided to Cowen and its counsel, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented;</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent:49.5pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(ii)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 35.1pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">a written opinion or statement of Choate Hall &amp; Stewart LLP, outside intellectual property counsel for the Company (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Choate Hall</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), or other counsel reasonably satisfactory to Cowen, in form and substance satisfactory to Cowen and its counsel, dated the date that the opinion is required to be delivered, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented;</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent:49.5pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(iii)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 31.5pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">a written opinion or statement of Perkins Coie LLP, outside intellectual property counsel for the Company (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Perkins Coie</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), or other counsel reasonably satisfactory to Cowen, in form and substance satisfactory to Cowen and its counsel, dated the date that the opinion is required to be delivered, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented;</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-indent:49.5pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(iv)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 35.1pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">a written opinion or statement of Rothwell, Figg, Ernst &amp; Manbeck, P.C., outside intellectual property counsel for the Company (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Rothwell, Figg</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D; and, together with Choate Hall and Perkins Coie, each a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Company IP Counsel</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D;), or other counsel reasonably satisfactory to Cowen, in form and substance satisfactory to Cowen and its counsel, dated the date that the opinion is required to be delivered, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">provided, however</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, the Company shall not be required to furnish any such opinions or statements if the Company does not intend to deliver a Placement Notice in such calendar quarter until such time as the Company delivers its next Placement Notice; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">provided</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">however</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, that in lieu of such opinions for subsequent Representation Dates, in each case, counsel may furnish Cowen with a letter (a &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Reliance Letter</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;) to the effect that Cowen may rely on a prior opinion delivered under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Section &#x200E;7(o)</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> to the same extent as if it were dated the date of such letter (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented at such Representation Date). The requirement to provide the opinions under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Section &#x200E;7(o)</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> shall be waived (i) for any Representation Date occurring at a time at which no Placement Notice is pending or (ii) with respect to any Representation Date, in Cowen&#x2019;s discretion. Notwithstanding the foregoing, if the Company subsequently decides to sell Shares </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">in an Agency Transaction </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">following a Representation Date when the Company relied on such waiver and did not provide Cowen with the opinions under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Section &#x200E;7(o)</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, then before the Company delivers the Placement Notice or Cowen sells any Shares </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">pursuant to such Agency Transaction</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, Cowen may, in its discretion, require the Company to provide Cowen with some or all of the opinions under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Section &#x200E;7(o)</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, substantially similar to the forms previously provided to Cowen and its counsel, each dated the date of the Placement Notice; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">provided</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;color:#000000;font-size:12pt;">however</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">, the Company shall be required to furnish to Cowen no more than one of each such opinion hereunder per calendar quarter. With respect to any Principal Transaction pursuant to a Terms Agreement, the Company shall cause to be furnished to Cowen on the Principal Settlement Date a written opinion of Company Counsel and each of Company IP Counsel, or other counsel reasonably satisfactory to Cowen, in form and substance satisfactory to Cowen and its counsel, dated the Principal Settlement Date.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(p)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Comfort Letter</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. On or prior to the First Delivery Date and within three (3) Trading Days of each Representation Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Exhibit 7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> for which no waiver is applicable, the Company shall cause its</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">19</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">independent accountants to furnish Cowen a letter (the </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Comfort Letter</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">&#x201D;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">), dated the date that the Comfort Letter is delivered, in form and substance reasonably satisfactory to Cowen, (i) confirming that they are an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board, (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#x2019; &#x201C;comfort letters&#x201D; to Cowen in connection with registered public offerings (the first such letter, the </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Initial Comfort Letter</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">&#x201D;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">) and (iii) updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">that the Company shall be required to furnish to Cowen no more than one Comfort Letter hereunder per calendar quarter. With respect to any Principal Transaction pursuant to a Terms Agreement, the Company shall cause its independent accountants to furnish Cowen, in form and substance satisfactory to Cowen, Comfort Letter at the applicable Time of Sale, dated the date of such Time of Sale, and on the Principal Settlement Date, dated the Principal Settlement Date.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(q)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Market Activities</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares or (ii) sell, bid for, or purchase the Shares to be issued and sold pursuant to this Agreement or any Terms Agreement in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Shares other than Cowen; provided, however, that the Company may bid for and purchase shares of its common stock in accordance with Rule 10b-18 under the Exchange Act.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(r)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Insurance</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company and its subsidiaries shall maintain, or cause to be maintained, insurance in such amounts and covering such risks as is reasonable and customary for the business for which it is engaged.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(s)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Compliance with Laws</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company and each of its subsidiaries shall maintain, or cause to be maintained, all material environmental permits, licenses and other authorizations required by federal, state and local law in order to conduct their businesses as described in the Prospectus, and the Company and each of its subsidiaries shall conduct their businesses, or cause their businesses to be conducted, in substantial compliance with such permits, licenses and authorizations and with applicable environmental laws, except where the failure to maintain or be in compliance with such permits, licenses and authorizations could not reasonably be expected to result in a material adverse effect on the Company and its subsidiaries, taken as a whole.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(t)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Investment Company Act</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor its subsidiaries will be or become, at any time prior to the termination of this Agreement, an &#x201C;investment company,&#x201D; as such term is defined in the Investment Company Act, assuming no change in the Commission&#x2019;s current interpretation as to entities that are not considered an investment company.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(u)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Securities Act and Exchange Act</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company will use its reasonable efforts to comply with all requirements imposed upon it by the Securities Act and the Exchange Act as from time to time in force, so far as necessary to permit the continuance of sales of, or dealings in, the Shares as contemplated by the provisions hereof and the Prospectus.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(v)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">No Offer to Sell</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Other than the Prospectus and any Permitted Free Writing Prospectus, neither Cowen nor the Company (including its agents and representatives, other than Cowen in its</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">20</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Shares hereunder.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(w)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Sarbanes-Oxley Act</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company and its subsidiaries will use their reasonable efforts to comply with all effective applicable provisions of the Sarbanes-Oxley Act.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">8.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Conditions to Cowen&#x2019;s Obligations</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The obligations of Cowen hereunder with respect to a Placement Notice or pursuant to any Terms Agreement will be subject to the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company of its obligations hereunder and thereunder, to the completion by Cowen of due diligence reviews satisfactory to Cowen in its reasonable judgment, and to the continuing satisfaction (or waiver by Cowen in its sole discretion) of the following additional conditions:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Registration Statement Effective</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Registration Statement shall be effective and shall be available for the sale of all Shares contemplated to be issued pursuant to any Placement Notice or any Terms Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">No Material Notices</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. None of the following events shall have occurred and be continuing: (i) receipt by the Company or any of its subsidiaries of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, the Prospectus or such documents so that, in the case of the Registration Statement, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(c)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">No Misstatement or Material Omission</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Cowen shall not have advised the Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in Cowen&#x2019;s reasonable opinion is material, or omits to state a fact that in Cowen&#x2019;s reasonable opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(d)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">No Downgrade</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. There shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any of the securities of the Company by any &#x201C;nationally recognized statistical rating organization,&#x201D; as such term is defined in Section 3(a)(62) of the Exchange Act that, in the reasonable judgment of Cowen, makes it impracticable to market the Shares on the terms and in the manner contemplated in the Prospectus.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">21</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(e)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Material Change</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. There shall not have occurred any change, or any development involving a prospective change, in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Prospectus that, in the judgment of Cowen, is material and adverse and that makes it, in the reasonable judgment of Cowen, impracticable to market the Shares on the terms and in the manner contemplated in the Prospectus.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(f)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Company Counsel and Company IP Counsel Legal Opinions</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Cowen shall have received the opinions of Company Counsel and each of the Company IP Counsels, each required to be delivered pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(o)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> on or before the date on which such delivery of such opinions is required pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(o)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(g)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Cowen Counsel Legal Opinion</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Cowen shall have received from Davis Polk &amp; Wardwell LLP, counsel for Cowen, such opinion or opinions, on or before the date on which the delivery of the Company Counsel legal opinion is required pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(o)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, with respect to such matters as Cowen may reasonably require, and the Company shall have furnished to such counsel such documents as they request for enabling them to pass upon such matters.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(h)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Comfort Letter</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Cowen shall have received the Comfort Letter required to be delivered pursuant </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(p)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> on or before the date on which such delivery of such Comfort Letter is required pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(p)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(i)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Representation Certificate</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Cowen shall have received the certificate required to be delivered pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> on or before the date on which delivery of such certificate is required pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(j)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Secretary&#x2019;s Certificate</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. On or prior to the First Delivery Date and at each Principal Settlement Date, Cowen shall have received a certificate, signed on behalf of the Company by its corporate Secretary, in form and substance reasonably satisfactory to Cowen and its counsel.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(k)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">No Suspension</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Trading in the Common Stock shall not have been suspended on Nasdaq.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(l)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Other Materials</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. On each date on which the Company is required to deliver a certificate pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, the Company shall have furnished to Cowen such appropriate further information, certificates and documents as Cowen may have reasonably requested. All such opinions, certificates, letters and other documents shall have been in compliance with the provisions hereof. The Company will furnish Cowen with such conformed copies of such opinions, certificates, letters and other documents as Cowen shall have reasonably requested.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(m)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Securities Act Filings Made</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the issuance of any Placement Notice hereunder or prior to any Principal Settlement Date shall have been made within the applicable time period prescribed for such filing by Rule 424. The Company shall file a prospectus supplement or a supplement to a prospectus supplement in connection with any Principal Transaction pursuant to a Terms Agreement within the applicable time period prescribed for such filing by Rule 424.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(n)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Approval for Listing</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">22</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(o)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">No Termination Event</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. There shall not have occurred any event that would permit Cowen to terminate this Agreement pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;11(a)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">9.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Indemnification and Contribution.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Company Indemnification</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company agrees to indemnify and hold harmless Cowen, the directors, officers, partners, employees and agents of Cowen and each person, if any, who (i) controls Cowen within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, or (ii) is controlled by or is under common control with Cowen from and against any and all losses, claims, liabilities, expenses and damages (including, but not limited to, any and all reasonable investigative, legal and other expenses incurred in connection with, and any and all amounts paid in settlement (in accordance with </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(c)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">) of, any action, suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified party and any third party, or otherwise, or any claim asserted), as and when incurred, to which Cowen, or any such person, may become subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based, directly or indirectly, on (x) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or the Prospectus or any amendment or supplement to the Registration Statement or the Prospectus or in any free writing prospectus or in any application or other document executed by or on behalf of the Company in connection with this Agreement or based on written information furnished by or on behalf of the Company filed in any jurisdiction in order to qualify the Shares under the securities laws thereof or filed with the Commission, or (y) the omission or alleged omission to state in any such document a material fact required to be stated in it or necessary to make the statements in it not misleading; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">however</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, that this indemnity agreement shall not apply to the extent that such loss, claim, liability, expense or damage arises from the sale of the Shares pursuant to this Agreement or any Terms Agreement and is caused directly or indirectly by an untrue statement or omission made in reliance upon and in conformity with the Agent Information. This indemnity agreement will be in addition to any liability that the Company might otherwise have.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Cowen Indemnification</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Cowen agrees to indemnify and hold harmless the Company and its directors and each officer of the Company that signed the Registration Statement, and each person, if any, who (i) controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (ii) is controlled by or is under common control with the Company against any and all loss, liability, claim, damage and expense described in the indemnity contained in </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(a)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto) or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with the Agent Information.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(c)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Procedure</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. Any party that proposes to assert the right to be indemnified under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> and (ii) any liability that it may have to any indemnified party under the foregoing provision of this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">23</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly after the indemnifying party receives a written invoice relating to fees, disbursements and other charges in reasonable detail. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section 9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising or that may arise out of such claim, action or proceeding.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(d)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Contribution</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or Cowen, the Company and Cowen will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than Cowen, such as persons who control the Company within the meaning of the Securities Act, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and Cowen may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and Cowen on the other. The relative benefits received by the Company on the one hand and Cowen on the other hand shall be deemed to be in the same proportion as the total Net Proceeds from the sale of the Shares (before deducting expenses) received by the Company bear to the total compensation received by Cowen from the sale of Shares on behalf of the Company.&nbsp;&nbsp;If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">24</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">relative fault of the Company, on the one hand, and Cowen, on the other, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or Cowen, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and Cowen agree that it would not be just and equitable if contributions pursuant to this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(d)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(d)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> shall be deemed to include, for the purpose of this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(d)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(c)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereof. Notwithstanding the foregoing provisions of this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(d)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, Cowen shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section 11(f)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(d)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, any person who controls a party to this Agreement or any Terms Agreement within the meaning of the Securities Act, and any officers, directors, partners, employees or agents of Cowen, will have the same rights to contribution as that party, and each officer and director of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(d)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(d)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(c)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9(c)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereof.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">10.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Representations and Agreements to Survive Delivery</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. &nbsp;The indemnity and contribution agreements contained in </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i) any investigation made by or on behalf of Cowen, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the Shares and payment therefor or (iii) any termination of this Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">11.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Termination</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Cowen shall have the right by giving notice as hereinafter specified at any time to terminate this Agreement if (i) any material adverse effect, or any development that could reasonably be expected to result in a material adverse effect, has occurred that, in the reasonable judgment of Cowen, may materially impair the ability of Cowen to sell the Shares hereunder, (ii) the Company shall have failed, refused or been unable to perform any agreement on its part to be performed hereunder; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided, however,</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> in the case of any failure of the Company to deliver (or cause another person to deliver) any certification, opinion, or letter required under </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Sections &#x200E;7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">&#x200E;7(o)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, or </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">&#x200E;7(p)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, Cowen&#x2019;s right to terminate shall not arise unless such failure to deliver (or cause to be delivered) continues for more than thirty (30)</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">25</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">days from the date such delivery was required; (iii) any other condition of Cowen&#x2019;s obligations hereunder is not fulfilled, or (iv), any suspension or limitation of trading in the Shares or in securities generally on Nasdaq shall have occurred. Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(h)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (Expenses), </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (Indemnification and Contribution), </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;10</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (Representations and Agreements to Survive Delivery), </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;16</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (Applicable Law; Consent to Jurisdiction) and </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;17</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (Waiver of Jury Trial) hereof shall remain in full force and effect notwithstanding such termination. If Cowen elects to terminate this Agreement as provided in this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;11(a)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, Cowen shall provide the required notice as specified in </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;12</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> (Notices).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">In the case of any purchase by Cowen pursuant to a Terms Agreement, the obligations of Cowen pursuant to such Terms Agreement shall be subject to termination by Cowen at any time prior to or at the Principal Settlement Date if since the time of execution of the Terms Agreement, (i) there has occurred any outbreak or escalation of hostilities or other national or international calamity or crisis or change in economic, political or other conditions, the effect of which on the United States or international financial markets is material and adverse and makes it, in Cowen&#x2019;s judgment, impracticable to market the Shares or enforce contracts for the sale of the Shares in the manner contemplated by such Terms Agreement; or (ii) trading in any securities of the Company has been suspended by the Commission or by the Nasdaq, or trading generally on the Nasdaq or the New York Stock Exchange has been suspended (including an automatic halt in trading pursuant to market-decline triggers, other than those in which solely program trading is temporarily halted), or limitations on prices for trading (other than limitations on hours or numbers of days of trading) have been fixed, or maximum ranges for prices for securities have been required, by such exchange; or (iii) there has been any downgrade in the rating of any of the Company&#x2019;s debt securities or preferred stock by any &#x201C;nationally recognized statistical rating organization&#x201D; (as defined under Section 3(a)(62) of the Exchange Act); or (iv) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities. If Cowen elects to terminate its obligations pursuant to this Section 11(b), it shall notify the Company promptly in writing.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(c)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">The Company shall have the right, by giving ten (10) days&#x2019; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(h)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;10</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;16</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> and </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;17</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereof shall remain in full force and effect notwithstanding such termination.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(d)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Cowen shall have the right, by giving ten (10) days&#x2019; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(h)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;10</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;16</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> and </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;17</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> &nbsp;hereof shall remain in full force and effect notwithstanding such termination.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(e)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Unless earlier terminated pursuant to this </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;11</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, this Agreement shall automatically terminate upon the issuance and sale of all of the Shares through or to Cowen on the terms and subject to the conditions set forth herein; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> that the provisions of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(h)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;10</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;16</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> and </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;17</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> &nbsp;hereof shall remain in full force and effect notwithstanding such termination.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(f)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">This Agreement shall remain in full force and effect unless terminated pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Sections &#x200E;11(a), &#x200E;&#x200E;(c), &#x200E;(d), or (e)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> above or otherwise by mutual agreement of the parties; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided, however, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">that any such termination by mutual agreement shall in all cases be deemed to provide that </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(h)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">26</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">&#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;10</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;16</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> and </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;17</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> shall remain in full force and effect. Upon termination of this Agreement, the Company shall not have any liability to Cowen for any discount, commission or other compensation with respect to any Shares not otherwise sold by Cowen under this Agreement, or otherwise, except with respect to reimbursement of expenses pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;7(h)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(g)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Any termination of this Agreement shall be effective on the date specified in such notice of termination; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided, however,</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> that such termination shall not be effective until the close of business on the date of receipt of such notice by Cowen or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Shares, such Shares shall settle in accordance with the provisions of this Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">12.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Notices</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement or any Terms Agreement shall be in writing, unless otherwise specified in this Agreement, and if sent to Cowen, shall be delivered to Cowen at Cowen and Company, LLC, 599 Lexington Avenue, 27th Floor, New York, NY 10022, fax no. 646-562-1124, Attention: General Counsel; or if sent to the Company, shall be delivered to Editas Medicine, Inc., 11 Hurley Street, Cambridge, Massachusetts 02141; Attention: Chief Financial Officer, with a copy to Wilmer Cutler Pickering Hale and Dorr LLP, 60 State Street, Boston, Massachusetts 02109; Attention: Rosemary G. Reilly, Esq. Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose. Each such notice or other communication shall be deemed given (i) when delivered personally or by verifiable facsimile transmission (with an original to follow) on or before 4:30 p.m., New York City time, on a Business Day (as defined below), or, if such day is not a Business Day on the next succeeding Business Day, (ii) on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii) on the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">Business Day</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D; shall mean any day on which Nasdaq and commercial banks in the City of New York are open for business.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">13.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Successors and Assigns</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. This Agreement and any Terms Agreement shall inure to the benefit of and be binding upon the Company and Cowen and their respective successors and the affiliates, controlling persons, officers and directors referred to in </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Section &#x200E;9</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> hereof. References to any of the parties contained in this Agreement or any Terms Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement or any Terms Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement or any such Terms Agreement, except as expressly provided in this Agreement or such Terms Agreement. Neither party may assign its rights or obligations under this Agreement or any Terms Agreement without the prior written consent of the other party; </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">provided</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">however</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, that Cowen may assign its rights and obligations hereunder or under any Terms Agreement to an affiliate of Cowen without obtaining the Company&#x2019;s consent, so long as such affiliate is a registered broker-dealer.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">14.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Adjustments for Share Splits</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The parties acknowledge and agree that all share-related numbers contained in this Agreement or any Terms Agreement shall be adjusted to take into account any share split, share dividend or similar event effected with respect to the Common Stock.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">15.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Entire Agreement; Amendment; Severability</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto), together with any Terms Agreement and </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">any other agreement entered into between the Company and Cowen in connection with the offer and sale of Shares pursuant to this Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">, constitutes the entire agreement and supersedes</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">27</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement, nor any Terms Agreement, nor any term hereof may be amended except pursuant to a written instrument executed by the Company and Cowen. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement and any Terms Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">16.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Applicable Law; Consent to Jurisdiction</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. This Agreement and any Terms Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to the principles of conflicts of laws. Each party hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan, for the adjudication of any dispute hereunder or in connection with any transaction contemplated hereby or by any Terms Agreement, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail, return receipt requested) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">17.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Waiver of Jury Trial</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. The Company and Cowen each hereby irrevocably waives any right it may have to a trial by jury in respect of any claim based upon or arising out of this Agreement, any Terms Agreement or any transaction contemplated hereby or thereby.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">18.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Absence of Fiduciary Relationship</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">. &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">The Company acknowledges and agrees that:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Cowen has been retained solely to act as an arm&#x2019;s length contractual counterparty to the Company in connection with the sale of the Shares contemplated hereby and any Terms Agreement and that no fiduciary, advisory or agency relationship between the Company and Cowen has been created in respect of any of the transactions contemplated by this Agreement or any Terms Agreement, irrespective of whether Cowen has advised or is advising the Company on other matters;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">the Company is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement or any Terms Agreement;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(c)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">the Company has been advised that Cowen and its affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and that Cowen has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship; and</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">28</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(d)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">the Company waives, to the fullest extent permitted by law, any claims it may have against Cowen, for breach of fiduciary duty or alleged breach of fiduciary duty and agrees that Cowen shall have no liability (whether direct or indirect) to the Company in respect of such a fiduciary claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company, including stockholders, partners, employees or creditors of the Company.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">19.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Counterparts</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. This Agreement and any Terms Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement or any Terms Agreement by one party to the other may be made by facsimile or electronic transmission.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">20.<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Definitions</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">. As used in this Agreement, the following terms have the meaning set forth below:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(a)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">Applicable Time</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D; means the date of this Agreement, each date on which the Company executes and delivers a Terms Agreement, each Time of Sale, each Settlement Date, each Representation Date, the date on which a Placement Notice is given, and any date on which Shares are sold hereunder.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(b)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 25.2pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">Agent Information</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201D; means, (i) the following information in the Prospectus: the last sentence of the ninth paragraph and the eleventh paragraph under the caption &#x201C;Plan of Distribution&#x201D; in the Prospectus and (ii) any written information relating to Cowen and furnished to the Company by Cowen expressly for inclusion in any document as described in clause (x) of Section </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">&#x200E;9(a)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;">[Remainder of Page Intentionally Blank]</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">29</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">If the foregoing correctly sets forth the understanding between the Company and Cowen, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Cowen.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;line-height:100%;margin-bottom:0pt;font-size:10pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<a name="_Hlk40429489"></a><font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:180.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">Very truly yours,</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:180.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-weight:bold;color:#000000;font-size:12pt;">COWEN AND COMPANY, LLC</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">By:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;"> /s/ Michael Murphy</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">Name:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">Michael Murphy</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">Title:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">Managing Director</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:180.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-weight:bold;color:#000000;font-size:12pt;">ACCEPTED as of the date</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:180.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-weight:bold;color:#000000;font-size:12pt;">first-above written:</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:180.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-weight:bold;color:#000000;font-size:12pt;">EDITAS MEDICINE, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">By:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">/s/ Michelle Robertson</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">Name:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:148.50pt;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">Michelle Robertson</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:247.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:32.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">Title:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:148.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;color:#000000;font-size:12pt;">Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			&nbsp;
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">30</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">SCHEDULE 1</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">FORM OF PLACEMENT NOTICE</font>
		</p>
		<p style="margin:0pt;text-align:center;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;">
			<tr>
				<td valign="middle" style="width:72.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:23.35pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:72.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">From:</font></p>
				</td>
				<td valign="top" style="width:23.35pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">[ ]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:72.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:23.35pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:72.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Cc:</font></p>
				</td>
				<td valign="top" style="width:23.35pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">[ ]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:72.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:23.35pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:72.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">To: </font></p>
				</td>
				<td valign="top" style="width:23.35pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">[ ]</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Subject: Cowen At the Market Offering&#x2014;Placement Notice</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Ladies and Gentlemen:</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Editas Medicine, Inc. (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Company</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;), and Cowen and Company, LLC (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Cowen</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;) dated May 15, 2020 (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;), I hereby request on behalf of the Company that Cowen sell up to [ ] shares of the Company&#x2019;s common stock, par value $0.0001 per share, at a minimum market price of $_______ per share. Sales should begin on the date of this Notice and shall continue until [DATE] [all shares are sold].</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">SCHEDULE 2</font>
		</p>
		<p style="margin:0pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">The Company</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Cindy Collins, President and Chief Executive Officer<br><br>Michelle Robertson, Chief Financial Officer <br><br><br><br><br></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;text-decoration:underline;">Cowen and Company, LLC</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Michael Murphy, Managing Director</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">William Follis, Managing Director</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">SCHEDULE 2(b)</font>
		</p>
		<p style="margin:0pt 0pt 5pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">EDITAS MEDICINE, INC.</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;"> [_________________] SHARES</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;text-decoration:underline;">TERMS AGREEMENT</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 5pt;text-align:right;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">____, 20__</font>
		</p>
		<p style="margin:0pt 0pt 5pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Cowen and Company, LLC</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">599 Lexington Avenue</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">New York, NY 10022</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Ladies &amp; Gentlemen:</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Editas Medicine, Inc., a Delaware corporation (the </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;text-decoration:underline;">Company</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x201D;</font><font style="display:inline;font-family:Times New Roman,Times,serif;">), proposes, subject to the terms and conditions stated herein and in the Sales Agreement, dated May 15, 2020 (the </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;text-decoration:underline;">Sales Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x201D;</font><font style="display:inline;font-family:Times New Roman,Times,serif;">), between the Company and Cowen and Company, LLC (&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;text-decoration:underline;">Cowen</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x201D;</font><font style="display:inline;font-family:Times New Roman,Times,serif;">), to issue and sell to Cowen the securities specified in the Schedule hereto (the </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;text-decoration:underline;">Purchased Securities</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x201D;</font><font style="display:inline;font-family:Times New Roman,Times,serif;">). Unless otherwise defined below, terms defined in the Sales Agreement shall have the same meanings when used herein.</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Each of the provisions of the Sales Agreement not specifically related to the solicitation by Cowen, as agent of the Company, of offers to purchase securities is incorporated herein by reference in its entirety, and shall be deemed to be part of this Terms Agreement to the same extent as if such provisions had been set forth in full herein. Each of the representations, warranties and agreements set forth therein shall be deemed to have been made as of the date of this Terms Agreement and the Settlement Date set forth in the Schedule hereto.</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">An amendment to the Registration Statement or a supplement to the Prospectus, as the case may be, relating to the Purchased Securities, in the form heretofore delivered to Cowen, is now proposed to be filed with the Commission.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Subject to the terms and conditions set forth herein and in the Sales Agreement which are incorporated herein by reference, the Company agrees to issue and sell to Cowen, and Cowen agrees to purchase from the Company, the Purchased Securities at the time and place and at the purchase price set forth in the Schedule hereto.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Notwithstanding any provision of the Sales Agreement or this Terms Agreement to the contrary, the Company consents to Cowen trading in the Common Stock for Cowen</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2019;</font><font style="display:inline;font-family:Times New Roman,Times,serif;">s own account and for the account of its clients at the same time as sales of the Purchased Securities occur pursuant to this Terms Agreement.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">If the foregoing is in accordance with your understanding, please sign and return to us a counterpart hereof, whereupon this Terms Agreement, including those provisions of the Sales Agreement incorporated herein by reference, shall constitute a binding agreement between Cowen and the Company.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;line-height:100%;margin-bottom:0pt;font-size:10pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:249.80pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:182.20pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;color:#000000;">EDITAS MEDICINE, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:249.80pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:149.90pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:249.80pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:149.90pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:249.80pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;color:#000000;">By:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:149.90pt;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:249.80pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:32.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;color:#000000;">Name:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:149.90pt;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:249.80pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:32.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;color:#000000;">Title:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:149.90pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Accepted and agreed as of</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">the date first above written:</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 33.74%;line-height:100%;margin-bottom:0pt;font-size:10pt;">
			<tr>
				<td colspan="2" valign="top" style="border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:182.20pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">COWEN AND COMPANY, LLC</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:32.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:149.90pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:32.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;color:#000000;">By:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:149.90pt;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:32.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;color:#000000;">Name:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:149.90pt;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:32.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;color:#000000;">Title:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:149.90pt;padding:0pt;">
					<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:center;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">Schedule to Terms Agreement</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Title of Purchased Securities:</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Common Stock, par value $0.0001 per share</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Number of Shares of Purchased Securities:</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2022;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> Shares</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Purchase Price Payable by Cowen:</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2022;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> per Share</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Method of and Specified Funds for Payment of Purchase Price:</font>
		</p>
		<p style="margin:0pt 0pt 6pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;">By wire transfer to a bank account specified by the Company in same day funds.</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Method of Delivery:</font>
		</p>
		<p style="margin:0pt 0pt 6pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;">To Cowen</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2019;</font><font style="display:inline;font-family:Times New Roman,Times,serif;">s account, or the account of Cowen</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2019;</font><font style="display:inline;font-family:Times New Roman,Times,serif;">s designee, at The Depository Trust Company via DWAC in return for payment of the purchase price.</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Settlement Date:</font>
		</p>
		<p style="margin:0pt 0pt 6pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2022;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font><font style="display:inline;font-family:Times New Roman,Times,serif;">, 20</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2022;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Closing Location:</font>
		</p>
		<p style="margin:0pt 0pt 6pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2022;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Documents to be Delivered:</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The following documents referred to in the Sales Agreement shall be delivered on the Settlement Date as a condition to the closing for the Purchased Securities (which documents shall be dated on or as of the Settlement Date and shall be appropriately updated to cover any Permitted Free Writing Prospectuses and any amendments or supplements to the Registration Statement, the Prospectus, any Permitted Free Writing Prospectuses and any documents incorporated by reference therein):</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;">
			<tr>
				<td valign="top" style="width:18.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:440.20pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">(1) the opinion referred to in Section 8(f);</font></p>
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">(2) the opinion referred to in Section 8(g)</font></p>
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">(3) the &#x201C;comfort letter&#x201D; referred to in Section 8(h);</font></p>
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">(4) the representation certificate referred to in Section 8(i);</font></p>
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">(5) the secretary&#x2019;s certificate referred to in Section 8(j); and</font></p>
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">(6) such other documents as Cowen shall reasonably request.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 6pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Time of sale: </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2022;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">] [</font><font style="display:inline;font-family:Times New Roman,Times,serif;">a.m./p.m.</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (New York City time) on </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2022;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font><font style="display:inline;font-family:Times New Roman,Times,serif;">, &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">[</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&#x2022;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">]</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Time of sale information:</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;">
			<tr>
				<td valign="middle" style="width:06.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:12.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Symbol;color:#000000;">&#xF0B7;</font></p>
				</td>
				<td valign="top" style="width:06.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:446.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">The number of shares of Purchased Securities set forth above. </font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:06.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:06.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td colspan="3" valign="top" style="width:446.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">SCHEDULE 3</font>
		</p>
		<p style="margin:0pt;text-align:center;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Compensation</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Cowen shall be paid compensation equal to up to 3.0% of the gross proceeds from the sales of Shares in an Agency Transaction pursuant to the terms of this Agreement.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;text-align:right;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Exhibit 7(n)</font>
		</p>
		<p style="margin:0pt;text-align:right;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">OFFICER CERTIFICATE</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">The undersigned, the duly qualified and elected _______________________, of </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;">Editas Medicine, Inc. </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(&#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Company</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;), a Delaware corporation, does hereby certify in such capacity and on behalf of the Company, pursuant to </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Section 7(n)</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> of the Sales Agreement dated May 15, 2020 (the &#x201C;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;text-decoration:underline;">Sales Agreement</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">&#x201D;) between the Company and Cowen and Company, LLC, that to the best of the knowledge of the undersigned:</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(i) The representations and warranties of the Company in </font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;text-decoration:underline;">Section 6</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;"> of the Sales Agreement (A) to the extent such representations and warranties are subject to qualifications and exceptions contained therein relating to materiality or material adverse effect, are true and correct on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date, and (B) to the extent such representations and warranties are not subject to any qualifications or exceptions, are true and correct in all material respects as of the date hereof as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date; and</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">(ii) The Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales Agreement at or prior to the date hereof.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">By:</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Name:</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Title:</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">Date:</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:avoid;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>edit-20200515xex5d1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!--HTML document created with Toppan Merrill Bridge  9.6.0.116-->
<!--Created on: 5/15/2020 2:04:17 PM-->
<html>
	<head>
		<title>
			edit_Ex5_1
		</title>
	</head>
	<body><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p style="margin:0pt 0pt 12pt;text-align:right;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-weight:bold;font-size:12pt;">Exhibit&nbsp;5.1</font>
		</p>
		<p style="margin:0pt 0pt 30pt;text-align:right;border-top:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"><img src="edit-20200515xex5d1g002.gif" style="width: 1.28125in; height: 0.1666667in" alt="Picture 1"></font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:50.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 7pt;">
						<font style="display:inline;font-size:7pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:50.00%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 7pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:7pt;">+1 617 526 6000 (t)</font></p>
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 7pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:7pt;">+1 617 526 5000 (f)</font></p>
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 7pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:7pt;">wilmerhale.com</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:50.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:50.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.00%;height:18.89pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">May 15, 2020</font></p>
				</td>
				<td valign="top" style="width:50.00%;height:18.89pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Editas Medicine, Inc.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">11 Hurley Street</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Cambridge, MA 02141</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Re:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prospectus Supplement to Registration Statement on Form S-3</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Ladies and Gentlemen:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">This opinion is furnished to you in connection with (i) the Registration Statement on Form S-3 (File No. 333-223596) (the &#x201C;Registration Statement&#x201D;) filed by Editas Medicine, Inc., a Delaware corporation (the &#x201C;Company&#x201D;), with the Securities and Exchange Commission (the &#x201C;Commission&#x201D;) under the Securities Act of 1933, as amended (the &#x201C;Securities Act&#x201D;), for the registration of, among other things, an indeterminate number of shares of Common Stock, par value $0.0001 per share (the &#x201C;Common Stock&#x201D;) of the Company which may be issued from time to time on a delayed or continuous basis by the Company pursuant to Rule 415 under the Securities Act, as set forth in the Registration Statement and the prospectus contained therein (the &#x201C;Base Prospectus&#x201D;) and (ii) the prospectus supplement, dated May 15, 2020 (the &#x201C;Prospectus Supplement&#x201D; and, together with the Base Prospectus, the &#x201C;Prospectus&#x201D;) relating to the issuance and sale from time to time by the Company of shares of Common Stock having an aggregate offering price of up to $150,000,000 of shares of Common Stock (the &#x201C;Shares&#x201D;). The Shares are to be issued and sold pursuant to a Sales Agreement, dated May 15, 2020, between the Company and Cowen and Company, LLC (the &#x201C;Sales Agreement&#x201D;). We are acting as counsel for the Company in connection with the issue and sale by the Company of the Shares.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">We have examined and relied upon copies of the Registration Statement and the Prospectus as filed with the Commission. We have also examined and relied upon the Sales Agreement, the Restated Certificate of Incorporation of the Company (as amended or restated from time to time, the &#x201C;Certificate of Incorporation&#x201D;), the Amended and Restated Bylaws of the Company (as amended or restated from time to time, the &#x201C;Bylaws&#x201D;) and minutes of meetings of the stockholders and the Board of Directors of the Company as provided to us by the Company for purposes of rendering the opinion hereinafter set forth.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">In our examination of the foregoing documents, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies, the authenticity of the originals of such latter documents and the legal competence of all signatories to such documents.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"></font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"></table></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;"><img src="edit-20200515xex5d1g001.jpg" style="width: 7.5in; height: 0.3944444in" alt="Picture 3"></font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:42.38%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;"></font></p>
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:57.62%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:42.38%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">May 15, 2020</font></p>
				</td>
				<td valign="bottom" style="width:57.62%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;"><img src="edit-20200515xex5d1g003.gif" style="width: 1.28125in; height: 0.1666667in" alt="Picture 2"></font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:42.38%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">Page 2</font></p>
				</td>
				<td valign="bottom" style="width:57.62%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">We express no opinion herein as to the laws of any state or jurisdiction other than the state laws of the State of New York, the General Corporation Law of the State of Delaware and the federal laws of the United States of America.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Based upon and subject to the foregoing, we are of the opinion that the Shares have been duly authorized for issuance and, when the Shares have been issued and paid for in accordance with the terms and conditions of the Sales Agreement, the Shares will be validly issued, fully paid and non-assessable.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, and we disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or opinions set forth herein.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">We hereby consent to the filing of this opinion with the Commission in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act as an exhibit to the Current Report on Form 8-K to be filed by the Company on the date hereof in connection with the issuance and sale of the Shares and to the use of our name therein and in the related Prospectus Supplement under the caption &#x201C;Legal Matters.&#x201D; In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Very truly yours,</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:03.22%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:46.88%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:49.90%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="bottom" style="width:50.10%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">WILMER CUTLER PICKERING</font></p>
				</td>
				<td valign="bottom" style="width:49.90%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="bottom" style="width:50.10%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">HALE AND DORR LLP</font></p>
				</td>
				<td valign="bottom" style="width:49.90%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="bottom" style="width:50.10%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:49.90%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:03.22%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">By: </font></p>
				</td>
				<td valign="bottom" style="width:46.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">/s/ Rosemary G. Reilly</font></p>
				</td>
				<td valign="bottom" style="width:49.90%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:03.22%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:46.88%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">Rosemary G. Reilly, a Partner</font></p>
				</td>
				<td valign="bottom" style="width:49.90%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
						<font style="display:inline;font-size:12pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:avoid;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>edit-20200515xex5d1g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 edit-20200515xex5d1g001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /?Z***
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M-<^6IMIER>" ,LHR?6LS3FU/3TCMF,ZZ0^L2A[TILEDA:,L'<@ @&8E=X R
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MAO7MMS!H0"2I&?O$<^M5K+Q'?2)9A8S/$J6J32R1%3,950EP<A5QO'RX))!
MQQD ZRBN?M+_ ,S4+6(1R#>5 +7#M@8N,9!.#]SOZC^ZN*T/B#4FL[1YH[-9
M;^*"2!E#%(C(0"'Y^;&1@C;DG''6@#J:*H:1>37UI(\XA\R.>2$F%B5.QBN>
M>G3IVZ9.,U?H **Q_$K2C3H5B,H9[N%"(IC$S N 1N!!'%8MMK%_9RRZ;$DK
M3BYE^6??<^0BI$VS?D,^[S0P)/RAB.=H% '945SB:M>W]NL^V.W@WV9"*Q9R
M9&C8C<#C #$=.<]N[8M9O0P$44(MH8()9!([M(WF2.A )/& F<G.<XXZT =+
M1110 45QNO27B:GJ\T3702TLX95>.[:-83^]+/Y>=LF H)!ZXQ6G)K5Y',)C
M';_9))YK9(V8K(&C5SN+$XP?+/&!@$'/44 ;]%<S#K&J375C;N;>*=KK9<1-
M"RD(8G<#!)'5#\RD@X[8(H/B"_2VBN&AM66[MGN;= 6#(%V85_7(?DC&#Q@]
M: .FHJAIEU<SF\ANQ$9;6?RB\2E5<%$<'!)Q]_'4],]\5?H **R/$TDL>A2F
M!I!(TL*#RY"C$-*@(##D9!(R*S;.[OK.6YLD)65KQ(XDNIFG$2-'NW;R=S<A
MCM)XZ< @T =316%)KL_V<&"WCDG>&Y>.,R!=S1R*@&3QSN]:IR^(KZ*V5S]G
M/D&3[9(8) 8MH1@#'DLN0^2PW@<'D&@#J:*Y6[\07K272)!LMRT]O&P5E=6C
M1SOW9P<E#A0,X.[/:KMOJUV-8AM)A$MO(1%&Q#%I6\K>2'&0",,-C ' W GI
M0!NT444 %%<?;M+#8?VE'>7;7;ZQ+;B.2X=TD3[8Z% A)483." "-N>@(J;_
M (2:_,5S.MDGEA)FA5P4P8V"@,<_-NSR0/E/'S=: .JK/U#2_MUW:W27MS:S
M6V\*82I5@P (96!!Z#!QD<X."0<Z;Q!/IGF'4HXVCBE>$R0*PW/Y2RH ISU!
M9>IRP7'WL"&V\0ZE+>LDMDB1K(UNZA6X=8RQ8,3@C(P% S@[L]J -^RLXK&V
M$$.=NYG9CU9V8LS''&2Q)XP.>,58JIIDUQ<Z;;W%SY7FRH)"(@=J@\@<]<#C
M/&?0=*MT %%8GB(2N^E01&4B:\*ND5RT!<>3*V-RD'&0#^%5_P"TKRT@O(T$
M48MY4MH4<R7$CR,J-R2<MC>>,\\9*@9H Z.BN7A\0ZC<6\\R0VR+9V_G3J^<
MN5DE1@N#A<^43G+8SCGK39=5O7TS6(('$4ULERZ32D[FQ(^"@ST4#&>Q &*
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M&<HQ&2IQC(]."1^-<G!KVHFTNM5Q"(TLTOWMY')"Q'?MC4\ -\C,6(/) Q@
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M-'9&9%9D.Y"1G:<$9'H<$C\34<MG;7$<D<UM#(DC!G5T!#$8P2#U(P/R%%%
M"1V-I#$T45K!'&R[&18P 5R3C'IEF_,^M*UK;MC=;Q'&[&4'\7WOS[^M%% #
M9+"SENENI+2![A0 LK1@N,'(P>O!)_.G&TMF\G=;Q'R#F'*#]V<8^7TXXXHH
MH FHHHH J?V7I_GO/]@M?.<DM)Y*[FR,')QGD4^"PL[5%2WM((55]X6.,* V
M,9X[XXSZ444 -ETRPN&1IK&VD*?=+Q*=O.>,CCGFE&G6*S2S+96XEF!65Q$N
MYP>H8XYS@=?2BB@"<(BNSA%#-C<P')QTS3J** &2Q1SPO#-&LD<BE71QD,#P
M01W%5&T72GA\E],LFB)W%#;J5SC&<8ZX-%% $WV"S^UB[^R0?:5&!-Y8W@8Q
MUZ]"14PC02-($42, I;') S@9]!D_F:** (Q:VZAPMO$ ^=X"#YLDL<^O+$_
M4GUK/@\/6L.J27YDDE=V=@DBIA2W7D*&/!( 8D ''I@HH NV^GV5HH6VM+>%
M5?>!'$% ;&,\#KCC/I3%TG34@>!=/M%AD8,\8A7:Q'0D8Y-%% %F&&*WA2&&
M-(XD&%1% "CT %/HHH :T<;.CLBETSM8CE<]<>E5Y=,L)XFBFL;:2-W,C*\2
MD,YZL1CK[T44 2-:6S[]UO$V^/RFR@^9.?E/MR>/>I0 JA5   P .U%% %5]
M+T^3R-]C;-]G_P!3NA4^7T^[QQT'3TJ<00@J1$@*N7'RCACG)^O)Y]S110 L
M44<$2Q11K'&@PJ(, #T I]%% #3&AD60HID4%0V.0#C(SZ' _(5 =/LC=_:S
M:6_VG_GMY0W],?>QGIQ]***  :=8K<I<BRMQ.@VK*(EW*,8P#C(XXJ?RT\SS
M-B^9C;NQSCTSZ444 1-96CQR(]K"R29WJ8P0V3DY]>>:1;&T2[-VMK MR1@S
M",!R.._7L/RHHH L4444 51IE@+E[D6-L)WSOE\I=S9&#DXR>*6WTZQLQBVL
MK>#!W?NHE7G!&>!Z$C\:** )PB!2H10I)) '!SR:00Q*L:B- L7^K 483C''
MIP2*** ((M,L('9XK&VC=R"S)$H+$'(SQV//UI9].LKD 3V=O* V\"2)6PWK
MR.M%% !+IUC.4,UE;R%&+(7B4[23DD<<$GGZT?V=8F::8V5OYLRE)7\I<R*>
MH8XY'L:** 'VUI;6<7E6MO%!'G.R) HSZX%3444 1SP0W4$D%Q%'-#(I5XY%
M#*P/4$'@BDDMX)9%DDAC=U5E5F4$@-U /H<#/THHH KC1]+$+0C3;/RF(9D\
MA=I(Z'&.M6%M;=$V)!$J_+\H0 ?+C;^6!CTP***  6MN%*B"(*0 1L&" <@?
M@23^-9\/A^TAU274"SR22;\JZICYNO(4,W' W$X!Q110!:72M.66&5;"U$D
I"Q,(5S&!T"G' Y/2K"PQ(RLL2*5!52% P#@D#ZX'Y444 /HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>edit-20200515xex5d1g002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 edit-20200515xex5d1g002.gif
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M P$" P$" P$" P$" P$" R'_"TY%5%-#05!%,BXP P$!   A^00!  #Q "P
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#0  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>edit-20200515xex5d1g003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 edit-20200515xex5d1g003.gif
M1TE&.#EA>P 0 /0  '=W=R(B(A$1$3,S,\S,S+N[NXB(B/___V9F9@   *JJ
MJIF9F>[N[D1$1%555=W=W0    $" P$" P$" P$" P$" P$" P$" P$" P$"
M P$" P$" P$" P$" P$" P$" R'_"TY%5%-#05!%,BXP P$!   A^00!   0
M "P     >P 0   (_P !!! @8 "! @,(!C!P $& ! ,4+$@H  &# Q@S:MS(
ML:/'CQT)-"!8L$#&B20=7 3)\B.#APHR(DC@(&.#FA@+)%C9LJ?/GS-Q;GRX
MX*?1C 82-,CX@.!%!@(>9 3@@,""!0H,$#A0P(""K%(S=I78D0%6 Q>O2EQ@
MX.K%!UBOM@V+- &"C@,2F-1HENX! EZS;A4;ERW;P0>@ZLWH( %# T)?$G@P
MT^Y6 HT3 .#)-3/BJ0D$%#V@X&$# P8 +*:<P*Z!O  T)A6J,>]>T PS$E!-
M\S/"! M1"Z"M6JC. 0<&W%: '&->N@0@AFP=>ZAFC8U''UA0/7D"J0SRYO\^
MD/0NQ[PQ:],\_YVC KNZ:3\(37<@ MH-M">D>[QC@8$#<+; 0^9AE)U&B"4T
MF&I+850>7HN)11)GR0GP&4;O=7> 7PU=YV!KMST0 $]Y(:93@QLI $ #":1G
MX(.,)3#: WZ5^&%SY$%4P(X\_M>B1@@8,)-VSEGHGH=_<:23 "LU%=54!5;(
MGW3N ?">4 I4A>0!!Y(WGI0&REA7  V4:>9($28VX@+KU?9DBO#]%:5-CM'9
MG4'JF:A41]P=\-!@!D4796,#W/1C1N(5 (  &L*X$7H9*= @034F<"%7P#DP
MTIP84NGDB*3AB-% 4XH:Z5VJQ5; 4CK1UI@!-#K_0"1L>:'X(6V(ING    (
M=&B1'))&$XU">@130U2)F=^C1N:TIWMW.<EE3*UB)R97MWG'@&(NYLBI=^F%
MAP  !K!(FXUP5F>61\6]Q$"K#YCJYYN8RGM KV%JZJRKUYYG9%*@W@KA7A/I
M!AR)]$:ZI4=0"=" >0!RBFZ]?!7E0'4%"'#MB=82^4!N"CH7I[<0IG>:1BSJ
M9ZELF.*J88SMW=L:AR_1JU, =!7+*Z("&"SJJQDQX$!N?V(4W:$LVIH141LF
M/%NN+JZZ'94.?ELM1O,I30 "&C>PU:JA#># V )\)4  Z0%@GDBAQ?;Q0 Z/
M_1QE70_F(]D$(8 89@HA3I!0=PRP*( !BFHL]DV,ED;039JF^6BWLF[$  ';
MTKCA Y5/1OE?#%B>6).83Y[89)4_0/KHI6MD>N@TTM5ZYS1VSA3FK<=>.^VL
&3V9Y0  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>edit-20200515.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7401.38943 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/15/2020 8:04:25 PM-->
<!--Modified on: 5/15/2020 8:04:25 PM-->
<xsd:schema targetNamespace="http://www.editasmedicine.com/20200515" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:attributeFormDefault="unqualified" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:edit="http://www.editasmedicine.com/20200515">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="edit-20200515_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="edit-20200515_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>edit-20200515_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7401.38943 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/15/2020 8:04:25 PM-->
<!--Modified on: 5/15/2020 8:04:25 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cover [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>edit-20200515_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7401.38943 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/15/2020 8:04:25 PM-->
<!--Modified on: 5/15/2020 8:04:25 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="edit-20200515.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType_637251698650118605" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_637251698650118605" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber_637251698650118605" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName_637251698650118605" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_637251698650118605" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_637251698650118605" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_637251698650118605" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_637251698650118605" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_637251698650118605" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_637251698650118605" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_637251698650118605" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode_637251698650118605" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber_637251698650128603" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications_637251698650128603" order="13" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial_637251698650128603" order="14" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_637251698650128603" order="15" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_637251698650128603" order="16" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle_637251698650128603" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol_637251698650128603" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName_637251698650128603" order="19" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_637251698650128603" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_637251698650128603" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey_637251698650128603" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_637251698650138583" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag_637251698650138583" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>edit-20200515x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="edit-20200515.xsd" xlink:type="simple"/>
    <context id="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2020-05-15</startDate>
            <endDate>2020-05-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_PGcDyYl0XUm5vAszdqxcKg_2_1">0001650664</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_HX22MgMDIUKd1UQfguPrTg_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Narr_tOuBe7Po_UulwbtvYd364g">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Narr_ftI-YgUDFU2eO5XdhOl90g">2020-05-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Narr_oYoUNf4No0a-WZa2MlvYhQ">Editas Medicine, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_X5uualFnzEKOCVjNzU8NqA_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_yssiStBleESOJH1ItaC1nQ_1_2">001-37687</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_id_D5l0qUU6aaSoNbIn1Fw_1_4">46-4097528</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Narr_gu4RpHEKfE6SpCEFHqwvfA">11 Hurley Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Narr_6S5fpzbNUkG5irx_burKfQ">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Narr_-uj_M6YbUU6evy2CEjvtLg">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_cPCTBxrnGkaEa2ktB6k8ZA_1_2">02141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Narr_0wnWwttC8UujftRwrkLPAQ">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Narr__mN_qAvY2ESZ1CC95dUDnw">401-9000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_aWuDZkUNDkyYwCEexiQ8Xg_2_0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_Ik-QeWLybEKKwJwqGO4ERA_4_0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_bKU1q5KtDE-G_MQbtzWmVQ_6_0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_5PKFB8PcsU2pzAqpk06jmg_8_0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_S0jQ6-83P0WJmCpKvECv9A_2_0">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_q_3HHMfKW0ibolWfh_K7qQ_2_1">EDIT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Tc_yvfb8Cmgm02dPMt_xT_QIw_2_2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow"
      id="Narr_iwvi-4VRGkyGYZ-MWa07gg">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="edit-20200515x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="edit-20200515x8k.htm">edit-20200515x8k.htm</File>
    <File>edit-20200515.xsd</File>
    <File>edit-20200515_lab.xml</File>
    <File>edit-20200515_pre.xml</File>
    <File>edit-20200515xex1d1.htm</File>
    <File>edit-20200515xex5d1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "edit-20200515x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "edit-20200515x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "edit-20200515_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "edit-20200515_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "edit-20200515.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "edit",
   "nsuri": "http://www.editasmedicine.com/20200515",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "edit-20200515x8k.htm",
      "contextRef": "Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "edit-20200515x8k.htm",
      "contextRef": "Duration_5_15_2020_To_5_15_2020_JKlsoBudLEG9zjmLPSA4Ow",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001558370-20-006724-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-20-006724-xbrl.zip
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MGP"I7X[9^_S@_>]GWO\#4$L#!!0    ( )6 KU"TQV D$1D  $26   4
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MD1EF)QGWJ^3YPVG3I1.$AE+^YO2D;?1('PNV&X38-::@V.-0 *1EWDR0:+L
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MY:>,/1JA*,RW''RWQ+UKYZ!\>QRY>]]KK=*%=S:"EG+<,BUZ(=8=,D49=W
M70X>!*2:?$G32IU1BOF3# GQ#>Y-LCL9GU-,.6"\#5M ,I0+_02*%'WH?3.Y
M/R1^:!O8B7F8\TE"IL)?:5<A'BQQ&U)<D>K<@PXMQQLE?DQRS5:RJNX3?"N,
M "./.L8QQXIIAL(Z.(=1.,^?:=3G0_.!Z0$CQN_^RJDMSH<)R +UGF>)S.D?
M>N\1P^/I#NC3,?W.2.^,],Y(T^GE0Y]JX_7,<S-AH(TZ"G3[B 9P0S+PO2&U
MZK*> K?NP#;S?'!AV&AMVKH.ID;H3^J>2:;1^ALEBK!SX/YL')_5O_YH_>R4
M6W<U36++^[)@EK@\F+4/9!Z!R\(]OR46X5I4P*N'%Q=F^OQXX]HD\W?AV'F&
M/+ = OWKQ)]RWR0([':XYY!&^^S+D=0,<5UR+X#["JMQGT@WG4MJN?3.?N_L
M=P_[7>%Q,]X_,UB'<[QHF]J^XHAWG8Z*<=MKZ4U7.A@!+\JK\:*L"K)8*2F%
M\L/,^/@J-N/*=5/D,6>;.MALR:#1O[.P1WST)?+M /Q^BCGJ<6>6EP^_L8QM
M2J1^+?7J7K]O!S1+"%&]BSBSO]/IK=&I>=E&C?[ \28@8UG]A%I>[L.<OLBS
M:,C+G9"-X3J.-%54790EW=*4LD@TV5)*&E8M4Z,1)D,JZ66EHLQ'A=K*E[WR
MWECZ?CO1+[]&P57YX*!]$9NBV9C4@7YT>K-?K]P*PGG//?-:-][MTIC43[=D
M&N/2D'2.P]NV>#AI?CVJU5(QJ3\DNB17?E-?[CTH\+:" K\M(ZT8%'AXGK^K
MC5LS39\$0?QQ8KM$2FWK="/Y<G#4.+8::GM0;QP<W8V&5FTUZU:2T%'D.V2"
MVJ%/2+C4QEVA/[ZKS'IY-?34X>N9?^6-W!1RU+9B#7[JK<[MH6+[8TV/_&/K
M8C7DU'%?9VGB+\7*#MH01E:.(L4H8\[ F7\.+6V6RSS%FQ#]T$[5;SJX360X
M*=0;/X;A27<UO)WB(,!&+PI(& ;O+OP:7/@_6KV=>\"VSG=[D(ED&N?UJ[VQ
M[Q[>X@8NW(9[ZFWY>^T9L:2")$OK<]W738FG.!4QGJB;?NZ#O-H#[*#&F!@1
M7731F04N!@G>G<&W1C=@:41Y^K?S^GYIFM?6[BS[@\(FE3X&*"0.&?0\ER"7
M13YV$,B!$U$:(@P6*>@GDU3CE,EX)BLHB>V-6RS42*D!H#,=QY9;<>1>C\*P
M7NY$/ZSP<N3?GIS75C135&EYG'R%+CXDF-LP%DX\D,US2L=TM)9A0NNWM+O:
M\%NAT?XNU>L5Q>SLNZ,58[6B)%1$4;Q7W6\\RWK[ "PRXL>)3#Z*+V,-#EQK
MT>0EMTM,U*:6%SK!01BG+OYCTYE>EIDGSNO$>H\8MRCL$80'8 L/?)M&OG5O
MC'0";BRE 7U(2</9OBP<(PNT(N@2.P#%$A+7! *%'@KL?N2$V"5>%#@3%, <
M VO"7H]?\'3@"YQ$T>D#?Y:[!K@#XF-WDCRS/ <@H.]1(]VF\=P ;0>$H$/B
M$A^6]:8+[T:IE-U:KI#C@'^HID-R1%5-J2RJFB3)EB9;!5G32TI1(Q5#U$E!
M$8NR.1\^J]>.+.>[WK0ZA<FWH??]<D .;N)#9]F65Q>GEY;Z51]WZFK7.?CV
MQ2T-OW8U>;%ET;Y0!->2]0[QE,)!+?PQB8RNIBZVU$:5/?W\0% [44/4R&E'
ME2="5RM/6SXK>+?YR%S*B/@-0E?/"<E5U-]Q8K'9OAEJK@=UFX=S'3;DYN,2
MNN<Y.@;=%X(:3AL$U[X=@KJEVUN1&V^4!%,?$%]'^]]O.ZW]V\FW4;U!QO9%
MF>DK<9D)F4R^3;H>09TF:D_Z8!@L+!;4Y*V49/GC0PGRZZ'_&E:S&$- EC2*
MT"!UQ.,R<@A?+.2"$B\Z8?94!SW,L2V5>*OZP27_4BB*.7AEWC]Y.[RZ@(W$
M3GU+%)J'Z8WA\$W)>]MS; -8TNV>@E$&EIDS%?;FK7!!KD\F>N/X>/1E='=X
M)C<N:V!R_(.$?88>U(_Q<X^D2S(6I$)*V#/GMI:(NBSF^#OOTOXN[:\D[><^
MH2L[+<S CIE2O\H_LZQ4FI9^W)'NE.-POR$<:J<7>OCSNO_U MR'?Y#4 YH$
M(X6GIZWUDFP*A6W]PZHZ@+_UK@7>M<"OT0+-((B(OTP7*.?'!WOE<R/H% 8_
M:W>#6U']T:<!@G==\)@N*!)!WC96U07Q6YO:GWAJ%HRXR9T)<1&D6;@VY2'Q
ML!WQB9G!<7Q\'J9!56T<Q@.49F)QIJ&7C4JAK!%9-32Y*%L:+JA8$\V*8:FZ
M3.-T\]&PK]K$Z5Q?WC1N)Q>:63RW[PI'N+LL/4ZWO]BZ63PX:!PV35>XD8;'
MIU>TY4*$K2PTG/V?DP._<[;_;>ST>C?CHCB*]TS_H/2X8C%7+#X_>K/0UPLB
M00M]/;BQ^H*U8C4$K"PGY?E0ZCT['^R.[=+,UJJPJ+X>+%5Q1<NZ\=(,1@\9
M#@Z":66)=5+L69-?K1+0W,1\S'8B^0JT3;?BGS>M]>[*OW1:R6E\1BZ2K">@
M#$<]&^[,-&9VNF^2OS-ENE["X)O<'HV7HXE4T)FL3"VCMOCC0A7*Q7/Q^DN_
M/C@>-NK#2NV^0.B4^%N[U/ "@K5#S[C=0?\GYF@5.C3 /AIB)R)H0 O7]=A!
MO^<:1QN6S5^>JQ0+-Y?M*47NM.+1T:EU?"W:</O:ZFG'I;N+>"OM(8HT]IM7
M:T3V'W&V:]Z5H+IF,8,QD8[$LIU5.:%'#X>67J[WNWVQ8)Z?AMKX2KMHCN*3
M 0_1@Y8_:N' Q'=<2M I]F])B$Y.ZH^2Z96R><J#UTWF>=!D;KHF=48(TB?(
M8#OMT/06E@3"SI7-[8#; 8(9@2=#>^NBKN^-PA[U:09T5QP'R"26[?+*+JEM
M#%%)3.VY/0Q>D*J(MFG#$M_ 2!K#6, 8 UH8AJ9>I+RC@BX4EG2XK-35M&?J
M'\%[&9+<4X&JL#!^CA5M7D]&5;P6%6>F>%5=,:&JL1S_V72I7Q@AX.F@"92'
M#,@ZAS&5(62/AK8@?[T\O)T<?OLNG%YCL=1=6A%KK:&!%\G/(J6:U@,20=/:
MEHJ7O9!;T@/A(0YXIR \KL=\U2@@K!70+<Y@H?6BV>8ZXE5>*4G86,Z$#DXK
MH[/T%!?F 4]\ CH%W@.1Q*Y!-Q^P8= J [0QK?!L8M\,>.Z*N=Q13N(1VSC.
M*8O%+BUKN9CQGDZW>4*EPF\KDZ>8,@0?J->:K<ZZK/QJJCKKLN*M]\4+GP7P
MHYUEZEW/J1%:]CO) UNBV^^+T&2SOIX*+>UHP9=8[;1AL6P1HX -C1B6J,D&
M+FCEDFIJ1"U;!5&2)*N2U+5*)87\S[^>E+V6*BH<HX1[!ETB\*05;($&KV)G
MA"=!;&B5R[F"/$UBFY*6%A]'K)0QFGV=I:H\L3ZR).5*ZGR!Y.3F&BLD;TWQ
M>^3<*D4%Q$F52S$>UV(DI!GI(;^R&9)^*N'TH:8@6%*.MN+MG_[WP5X;M&X*
M3?3S$$;)1C3:IZ:(S5+J:UV?L/!K;AT%>I>LX$M0=N:B=/7&';2T/!_:IMKT
M/W>1%WZ,ETA^\0$Q6YV94FQ>:=</M;%#+:AD6NE>YAXEO;&UH>Z-B LKA(GJ
MR0(%=O$.-=Q 8&@_"230+GYS)[,L\% !'2WN =8S0#W= V#]!L1QN ?*SC?0
MZGX&!SQXU&?=@45PR#+  <8N3*#+2W]:0$^68DE_)P,ZC084DO^3%'$'NJ+_
M,_-G@T^!MWROCT(@*WV'?_9 CW039*3>/(M'BM_-H1K803LT0)(E9'KV8"3&
MF:.8KJ/! );-*$!!-!@XG#0,\7.6*L74= 5-U0*P:5Z0Z\8QZNF;"6!I8,]G
M@[6G@R7$YML&%/ED# 8& R^"=0\TAP&X)HXU-3W82.R<&>U@)R:P3@P:+"(P
ML,$DB"'!AR=2@:)!*J-M7KC RZ%BL2@4"D6EH@*^Z=0HE/3G/=(8H08H9JX!
M]2N([>9>1PP[ P#=) Y,PF=YNT G!\>;,6!H 4]QH(-(_P&@,C8!^$'V^IQ0
M +EI\]V:Q.?(BMA.S$I4$AC_LS9<!L#LZX,GY9G4-8+6+ U9I[(2TQ&'K'F?
M>ZE>A@67.%1(EA2PQ;;E#Q2Y_<CILA^JN3=)+':PN(CWF1F98R6"T^([#S2,
MA?O43N0(H" R@G#034)QPX#2)QEA6)2UER!5C\#?Y(:QZZ43LVDB-X4XE8@]
M SPM+Z_$8FET@M6=8H8(N!\F"S<YRJ@^RPAT1+F3<V&"(X_YW: >P\D\7_)'
M,]3EXK%&]!>0:+U50%7 T,BU.?2-F?HE/K7^G0E(/0X\E^T:@6Q[/E 8!-5F
MXAG0Z&^BL*CN<*F_YU"O@Y_+H<"PW@<^#$;/J''V .T#/@[?B:(SI#<M8K+\
M=P>/=I ?.7%;T#J1$V]])IJ"/XTK5\>AFT/' \\2F)EZ1'$(YQ=0L\<61N!(
M)K8#("E'N#%5V0%SP2BV OY#3EQZ#*YS$T+$?$FQMYQCN;C-%C?P3_ZB5V#R
M!LQ!,P"&(!:PY3VE5^DE\I25>C8Q6-W2L^->X)2EJ!<;!7318+:52?KNK/9)
M+,*A;X.4TAO,S U>B40U&'LPN4=QL!A5&&+PMDU*@<:X![Y*R'[FBZX\U)@"
MZ-G)D*1&$K3DBQ+5:-,?G^$H _J"^TK):9+ \.U!^G#(-*N/:[9[(#(]$C"G
M'FC$BIIS1<H<=Q(+#,!S%V$G4Q>9EIL!@"<9J)CZB]@.#IO8*^'\VG;HR:=Z
M%#KP<6X;MUR#'5%.I!/8]WP?K,GS'41##*"@$T:<FIJ4Z9BE"'1!#EAW#O(&
M8*)3]F%>#727,"_C:;# II1F4\Z\E#XS2-^A*HP+&[T[,S1V[N,(9<H1KZA:
M8FF%/_>E*-!PTM3NXL;:9=I8:R?&&M7O]-03:@O%Y>;8TZTQ;@,EY@?7:BGE
MPE88G?*[26U!9\(-&SQ;OI?:HU2" /GUR/<IO'%)_P1L>DX+#'_HF<H&)5]H
MAQ&3!P[)=*4'8 *>2CL]FI5NHT?,#H$I!E/K9X<N7W'W;([<ZIJD56?F!::W
MZ7.VAMG)KBCC.S;2SAP,/N]JY$6.23N/7%CLK,BACHK'X,K8V' K%O!8A\YL
MMA00T,64VX.DQ-N/5'&WE[#JB_W[RD;<]X-I>'+*VHF+Q 0U6*?7+E5RLO(@
M+K;-.-29#,]&?J.'V3(;B&JN5/I-ZP,];8*%G%C^HR=8 2OE5YY*?,423YQ9
M'__1M(VF9SX<5N3RSVL@M;S<<[* .,?>/TNVI3.@/R83;G:F3\ZZ7L:/KT^E
ME^0Y[<_L]*693$_*#'Y,EVYD6H#MYS'8VV6=S8HO1DM^;71,QI(IY7IA_Z'-
MY,<&XI?TQ2H/A&2VP>);*7K2-7XN0VLQIF4R7Q,SJSD;5-9YM$<GX8@0-Q-6
MX_%Z\,JG>VMX%ZW"U2L9"1MA;.6=L5?+'+J/L95?QMAGL:L.G/OD6$"*87\O
M?BT4WQGV=V?8>AP/6H5AT?8T>F2[Z4#1A]^6E251_O6<_$J%SMZ8>7+%HI)#
MMIW3)4GT_L& V$Z<91=R#FRZ--D'W>Q=GCR6IKJ8(6.Q?T_.]$D329+CN(CX
ME)K'68*E:E?17"KEZ>1[$5]-07[""35>8&NU+*:R5;%4V5 U4Y9U39;ELJ:;
M2D4S1-$22VI!TI7D6-;K9#&5U)Q<NB>+B><;H=3WMYS'M*$R;BE&:#</6[6K
MSF6C_3J1_O.YS3B?W$6V'X<VGY:YG-ZRWUF6+6I&S@09. I8%-\.XI_$C3>7
M L +//#X3I).>MBQDOUZ%GF.&]#0>$0SC%AW. I[G@\S-G,;C7JR?@4'3[PH
M/G+XY#@HC$IE\_-68>M1)UX1WXI!MM%*K:^XLJZ"?;F4JVS:(J;';VIM= J?
M]6:KL8.:K7KNZ6?7WIGICV&FM=1M4#9,8OJCX-75"AUO&J3L3XS_8WCOL=D5
M<Y4-E)C.3'!OLB(K<)CF@O&#\6MNF.2#/#JUC1YQP"ZX]'2 -:!A]G453EDS
MM[\QIEJW,+^QZ?VS-<+SQ)B?3WI5&5Z47\3W..L]FUAHEH[!?XG ?_UR]R^B
MY[KA^A,@65=$(ET[)HX%9*K'9.]1WBZ*2P,90\\V[XECS'(+=,^<P$<O[#N[
M_P]02P,$%     @ E8"O4+S4.ZL=H0  T0,& !<   !E9&ET+3(P,C P-3$U
M>&5X,60Q+FAT;>Q]:7/;6);EYYZ(^0^8ZIX.*0)665YRL6HJ0FD[JQWMM-VV
M*VKZT\0C\4@A#0),+))9OW[N]C8 I"A9H&@1'=&5%@D"#V^YZ[GG_N5_/7KT
M'Y]_>QLEQ;19Z+R.IJ56M4ZBJ[2^B#X7RZ7*H]]T6:99%OU2ILE<1]'/)S^<
M/#XY/?WAT:.__L__\1>XQTOY59&_B)[_^?3YGY\\?O(X>O+B\;,7IS]$'W[C
M"R_J10;__9>_7&B5X#_^Y2]U6F>:_ODO.DGK__?ZZ^G_.Z5O_FR_^LN?S?5_
MF13)ZJ]_2=++J*I7F?X_?UJH<I[FCS(]JU\\/_GIIR=/GS_Y^=GIZ8\_//OQ
M?Y_)MV4ZO^C[^D]__<N?X5YW>4,:^C*\V8O'R_JLUE_K1RI+Y_D+^O79M,B*
M\L6_/J;_.\O27#^ZT'3?T\>/__?9K,CK1S.U2+/5B\_I0E?1.WT5?2P6*H_I
M[[C293KCZZKTG_I%=/H$GL-#^)>_X.=F&$E:+3.U>I'F^)B;W?J*QS0ILJ0U
M9/=D>?#KKQ?I)*VCTY/3O_P9O^79^/-RJUF9PN[3Y7U/B_\^_YY/JN79[5_E
M0:PI'$I5@01(TBD\)X[>Y-.3[VA*QO4,Y^#?3I\_CN$;_/_O:";N<AD?FN"E
M-TSTM"A5G8(";O)$E_2\/_WUY?O??GO_+OKT^?W+_QQG;)L9^W3^]O6GZ/QO
M'U^__NWUN\];3EJ$__^\3\WO[6SY1^HWM8KD3>_B_M?(H-/G=_BLSMWC"&W/
M0Y-MOS=5G<Y6_)'\ 4^!%WJ4)KJ8EVIYL9=[\9J]\K*XTGFD\B1Z62S %UG%
MT=NW+\<)LA/T_.>?H[?Z:YK/ZR*/SB]UWNAQ>NSTX(_^NRB_Q-&[_XY@S$^>
M##4Y#\%Q>:B[X*U*4O@MBI&_@93/]$+G+\:-T/>B*=A">?WBZ0^'L3-Z_=LX
M4M$KG:DK5>H(K,2E&(K147VAHW__UZ]/'I^^/+MK(^9N#'[6DKLSYG@V7IT=
MQS!3^2PM%U64UG#6YJ76%%&$24NK_9ZU<S/8>Y@WCK3VVSG1T5Y/&PWZ7K8:
M'-E9D67%574S,?Y=2;=;2W+R1MWJ^2_]'8KHTY/!'])YNVWOZL\O;C(_>X!_
M+U62@&E.B_+DIY.?9&T>TXN9DS.8,[SI[+ZIJD;E4TTRYY/*=%3,HD\7H/&J
M(;WSD^@SJ%"1<:PDJJB^4'4<S<IB$=7PXZ@N^+])4\+D1:ATX2@N<(2D2ZRX
MCB-0RN9KMN^J9O*[GM9TCPO4WCEH>'CY*JIT#4*C!&%[H4N=LK3%47RF'Y\[
MA97H&;QD$DTT2!B0-FD=+=0J2F'*>+XJG67XA**$AY1%,Q<!#H)I6N.0%2I
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MW.JQ//S%4Y.H>NIG1.@][GH"[_Z& V^XK?;:_AWNVT-/OD,YM,X8"'2^J/E
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M_&Y^+TD*YV'4D8@D7&-)?&AW^IG4=Q:=_OSL<=".X0BOWS,R__[A[X+6__A
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MV& )6DN%LY[F*/M6G?WH;V 7+#<K.Y66:PJK6K=ECZ+YX,WO$J!T=YI _.M
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MYFD/^4)?_WU'<_$?H,I_4[^##>P=+G/<]FY:_N.WS[L+53.8$+Q3?8G00T^
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MI%17&).<B6L63/\%U:5.^*XZ.5 I^6 Z.P^?F[J!1'S%J1BR1)V)=A9]<HF
MEP2['[C<X-4M<DR>Q/BV'%.'9-)V4NF6],1[D9'JF)DWD%/<.,DUN?,&6E$S
MM\I43Z4V*].V%Y$-A.#XL*I[BV,922\/&6CW? 3:C4"[!P^T^RZ$*NIJ#$JD
ME-/'B(X07S.[3^ZU/0-EDY9&%Q/C7,/8E"HZJCDT1X$N4\K'G84L<9(+73EE
MZA<.'HO&6Y(R-+1/2#>#[L,E]7#\NFHW$_5X%'JYK%HAW[X0E:_P)0I91:=/
MCQ0H<_C/%/_S#/[_^5%R;!ET*$Q&X5KC.<$W_2]V$KV9&: .NS5L17F]@+&P
MH&K'CASIDF=D*6)?R#FDQ^5H+J"',3AR2(3<#TNJ8"7*1KMY(K?'D>!@/R9R
MU9!@'BL2:J+Z;ET0L-%3B)<\1S?W4K)D.[]D%*(7ZRRTPVCXKN,4Y@E@)4#.
M)O0WKF_O=''GEV D- GMF.;6 (W0W.HSI7I0)^)[!J%#*N0@/SPL/'?5D[VK
MWQ.I=I&%;WFS(XEO(T%27K7[@QU'52'E9^!VE&A7T[@J_VZ%#3F4IG94^LN8
M#H2[B\><[4%:_S#!#/>9;33G OTS<!C5RL_=2NAF35XC1@DB@FAMWZG4E)7C
MIQ/$ %'9%/ZC57T*!R6!$UX,ZF4?9N#HP;3@W&-0\UOI]F&UT2XCZ1MB1RW#
MYMZC1]]_\(@2OMX+\7QE:<5=:*)WJDK4'P<J:AY,P\N]C5&OL4VEF9B<\]W5
M$JV!?@BMIRGXOLY6GA;+5%^;2FO),D^2H$^[!9#".%",8,$?>2ATXM'Y!A@Z
M-1=;#]&X30W)EA)ZF]*1<(:N':;O0]F7VQ*'8R:9W%1"QDR)IZ@"Z\Y@52P$
M<$G$^@Q/\7N=_H'RG=\$?N"X<VS0/3(Q%>]F!F=.1 ZJBV@S]0><;<[ 0S,[
M-]R H?]*KZ!-J $6'@3'%TU4MKQ^EL7'6R_160B(.[LW+B7Q+.)!:;P[OD1
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M/FJJ0325WZ2/)$]U%KUT\=AA5=-[BM@$/<-^I<)O2V/VBMB/36DAQW+0Y.:
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MX524HRD74]@-Y9.N:W'A\3P?: RT&&.@ QS+MWH..^P]@U$'SL7=(.!YK<=
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M<W&=83.T1$(KIOW%,Q*WINI K;CI:,4-9,6!*O8EKK7JWHN2'M:L$[)4VZB
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M'7@)&P2V8FC\N_;B(^=Q8[^&XZI.^DB*0=>@V=#YOCH[=_09F,C1D]_,\7O
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ML4+$WL$\V:\X#!ACA5TN#.8\(EU;/'2%8Z@ S]5L?/1@$@U]R0=7U*@!"M9
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MFW,^OV]L/K#<@L#R?2JCS<:589+_\Z]N&HW>XB3[^2!^^_]02P,$%     @
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MW?C*?:LG?D9')&S7"&YJOQNR:U=.B16R&K T[XB6AQU8GB K=SF/?@O\C^%
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M":O,C0<?".RD.!JZ%(T5$K>AZ3S"?(:L^8LY;1#*80<# 1(Q,*9:0#&!B)8
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M7G<E3/1 YDEL"Q:BQY1"XUIZ-IEO/92GBG6.R0)M=XS0*(>APL",[)IK6UE
M?X8YUAI1>6)?6#]/J,,!<O$EQ^HIIM)8Q#'%K1UW("/H+THH3QT770C7SLTA
M7_$5!Y5@/=A[5U\E11B6!0CHH66N(N?3$O2."I>09O_-,?GNDFCP68_"9LGR
M<,42F;E4FZ\AX@:+T%X/EQV2+M0+P[P6](R"GR@0L?8 \G5'N)BUOX)A_1!/
M+!!1ZQ5TS"E@+/(3"DS"%2MSJ2>&I60G"#>[+S?;MKQ[40*'7-9_7USBQO*
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M_@]02P$"% ,4    " "5@*]0$;X+UUX#    #   $0              @ $
M    961I="TR,#(P,#4Q-2YX<V102P$"% ,4    " "5@*]0M3Z0$VL%  !D
M/   %0              @ &- P  961I="TR,#(P,#4Q-5]L86(N>&UL4$L!
M A0#%     @ E8"O4-8+Q0"4!   +"<  !4              ( !*PD  &5D
M:70M,C R,# U,35?<')E+GAM;%!+ 0(4 Q0    ( )6 KU"TQV D$1D  $26
M   4              "  ?(-  !E9&ET+3(P,C P-3$U>#AK+FAT;5!+ 0(4
M Q0    ( )6 KU"\U#NK':$  -$#!@ 7              "  34G  !E9&ET
M+3(P,C P-3$U>&5X,60Q+FAT;5!+ 0(4 Q0    ( )6 KU!/6*9*<0L  (E*
M   7              "  8?(  !E9&ET+3(P,C P-3$U>&5X-60Q+FAT;5!+
4!08     !@ & )$!   MU      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MUQ]^5V'KM=F9?VQ\$>Q:^'47W1=02P,$%     @ E8"O4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MFM&55?&O+KSU+RF)  JF8<?R$J$@?I,Q[7A<:Y;4!E>5V"C'WFPZ7SNIG"3
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M7PW_R?(+4$L! A0#%     @ E8"O4!\CSP/     $P(   L
M ( !     %]R96QS+RYR96QS4$L! A0#%     @ E8"O4"?HAPZ"    L0
M !               ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "5@*]058>C_.\    K @  $0              @ &9 0  9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "5@*]0F5R<(Q &  "<)P  $P
M    @ &W @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )6 KU".
M+<[@GP(  )@+   8              "  ?@(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "5@*]0R#<3FE@"  #^!0  %
M    @ '-"P  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4    " "5@*]0
MNJ$YBM<!   R!@  #0              @ %7#@  >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( )6 KU 6;2-_0P$  #P"   /              "  5D0  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "5@*]0_\ F"+T   "% @  &@
M            @ ')$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " "5@*]0"X_8 R$!  !7!   $P              @ &^$@  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "@ * ( "   0%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6622142880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 15, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 15,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Editas Medicine, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4097528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11 Hurley Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">401-9000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EDIT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001650664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
